SHARE EXCHANGE AGREEMENT among SINGAPORE EDEVELOPMENT LTD., GLOBAL BIOMEDICAL PTE LTD., DOCUMENT SECURITY SYSTEMS, INC. and DSS BIOHEALTH SECURITY INC. dated as of April 21, 2020
Β
Β
Exhibit 10.38
Β
Β
among
SINGAPORE EDEVELOPMENT LTD.,
GLOBAL BIOMEDICAL PTE LTD.,
DOCUMENT SECURITY SYSTEMS, INC.
and
DSS BIOHEALTH SECURITY INC.
dated as of
April 21, 2020
Β
Β
Β
Β
Β
Β
TABLE OF CONTENTS
Β
ARTICLE
I DEFINITIONS
|
1
|
Β
|
Β
|
ARTICLE
II PURCHASE AND SALE
|
10
|
Section 2.01
Purchase and Sale.
|
10
|
Section 2.02
Purchase Price.
|
10
|
Section 2.03
Transactions to be Effected at the Closing.
|
10
|
Section 2.04
Purchase Price Adjustment.
|
11
|
Section 2.05
Closing.
|
11
|
Section 2.06
Withholding Tax.
|
11
|
Β
|
Β
|
ARTICLE
III REPRESENTATIONS AND WARRANTIES OF SELLER AND SED
|
12
|
Section 3.01
Organization and Authority of Seller.
|
12
|
Section 3.02
Organization, Authority and Qualification of the Company and
Subsidiaries.
|
12
|
Section 3.03
Capitalization.
|
12
|
Section 3.04 No
Subsidiaries.
|
13
|
Section 3.05 No
Conflicts; Consents.
|
13
|
Section 3.06 SED
Stockholder Approval.
|
14
|
Section 3.07
Financial Statements; Accounting.
|
14
|
Section 3.08
Undisclosed Liabilities.
|
14
|
Section 3.09
Absence of Certain Changes, Events and Conditions.
|
15
|
Section 3.10
Material Contracts.
|
17
|
Section 3.11 Title
to Assets; Real Property.
|
18
|
Section 3.12
Condition and Sufficiency of Assets.
|
19
|
Section 3.13
Intellectual Property.
|
19
|
Section 3.14
Privacy and Data Security.
|
21
|
Section 3.15
Inventory.
|
23
|
Section 3.16
Accounts Receivable.
|
23
|
Section 3.17
Customers and Suppliers.
|
23
|
Section 3.18
Insurance.
|
23
|
Section 3.19 Legal
Proceedings; Governmental Orders.
|
24
|
Section 3.20
Compliance with Laws; Permits.
|
24
|
Section 3.21
Environmental Matters.
|
25
|
Section 3.22
Employment Matters.
|
27
|
Section 3.23
Benefit Matters.
|
27
|
Section 3.24
Taxes.
|
28
|
Section 3.25 Money
Laundering Laws.
|
30
|
Section 3.26
Foreign Corrupt Practices.
|
30
|
Section 3.27 No
Disagreements with Accountants and Lawyers.
|
30
|
Section 3.28 Books
and Records.
|
31
|
Section 3.29
Brokers.
|
31
|
Section 3.30
Investment Representations.
|
31
|
Section 3.31 Proxy
Information.
|
33
|
Section 3.32 Full
Disclosure.
|
33
|
Β
|
Β
|
ARTICLE
IV REPRESENTATIONS AND WARRANTIES OF BUYER AND DSS
|
33
|
Section 4.01
Organization and Authority.
|
33
|
Section 4.02 DSS
Stockholder Approval.
|
34
|
Section 4.03 No
Conflicts; Consents.
|
34
|
Section 4.04
Investment Purpose.
|
34
|
Section 4.05
Brokers.
|
34
|
Section 4.06 Legal
Proceedings.
|
34
|
Section 4.07 DSS
Shares.
|
35
|
Section 4.08 SEC
Reports.
|
35
|
Section 4.09 Proxy
Information.
|
35
|
Β
Β
Β
ARTICLE
V COVENANTS
|
36
|
Section 5.01
Conduct of Business Prior to the Closing.
|
36
|
Section 5.02
Access to Information.
|
36
|
Section 5.03 No
Solicitation of Other Bids.
|
37
|
Section 5.04
Notice of Certain Events.
|
37
|
Section 5.05
Confidentiality.
|
38
|
Section 5.06
Non-Competition; Non-Solicitation.
|
38
|
Section 5.07
Governmental Approvals and Consents.
|
39
|
Section 5.08 Books
and Records.
|
41
|
Section 5.09
Closing Conditions.
|
41
|
Section 5.10 DSS
Stockholder Approval.
|
41
|
Section 5.11 DSS
Proxy Statement.
|
42
|
Section 5.12 SED
Stockholder Approval.
|
42
|
Section 5.13 SED
Meeting Circular.
|
42
|
Section 5.14
Public Announcements.
|
43
|
Section 5.15
Further Assurances.
|
43
|
Β
|
Β
|
ARTICLE
VI TAX MATTERS
|
43
|
Section 6.01 Tax
Covenants.
|
43
|
Section 6.02
Termination of Existing Tax Sharing Agreements.
|
44
|
Section 6.03 Tax
Indemnification.
|
44
|
Section 6.04
Straddle Period.
|
45
|
Section 6.05
Section 338(h)(10) Election.
|
45
|
Section 6.06
Contests.
|
45
|
Section 6.07
Cooperation and Exchange of Information.
|
46
|
Section 6.08 Tax
Treatment of Indemnification Payments.
|
46
|
Section 6.09
Survival.
|
46
|
Section 6.10
Overlap.
|
46
|
Β
|
Β
|
ARTICLE
VII CONDITIONS TO CLOSING
|
46
|
Section 7.01
Conditions to Obligations of All Parties.
|
46
|
Section 7.02
Conditions to Obligations of Buyer.
|
47
|
Section 7.03
Conditions to Obligations of Seller.
|
49
|
Β
|
Β
|
ARTICLE
VIII INDEMNIFICATION
|
50
|
Section 8.01
Survival.
|
50
|
Section 8.02
Indemnification by Seller.
|
50
|
Section 8.03
Indemnification by Buyer.
|
51
|
Section 8.04
Certain Limitations.
|
51
|
Section 8.05
Indemnification Procedures.
|
52
|
Section 8.06
Payments.
|
54
|
Section 8.07 Tax
Treatment of Indemnification Payments.
|
54
|
Section 8.08
Effect of Investigation.
|
54
|
Section 8.09
Exclusive Remedies.
|
54
|
Β
|
Β
|
ARTICLE
IX TERMINATION
|
54
|
Section 9.01
Termination.
|
54
|
Section 9.02
Effect of Termination.
|
55
|
Β
Β
Β
Β
ARTICLE
X MISCELLANEOUS
|
56
|
Section 10.01
Expenses.
|
56
|
Section 10.02
Notices.
|
56
|
Section 10.03
Interpretation.
|
57
|
Section 10.04
Headings.
|
57
|
Section 10.05
Severability.
|
57
|
Section 10.06
Entire Agreement.
|
57
|
Section 10.07
Successors and Assigns.
|
57
|
Section 10.08 No
Third-party Beneficiaries.
|
57
|
Section 10.09
Amendment and Modification; Waiver.
|
57
|
Section 10.10
Governing Law; Submission to Jurisdiction; Waiver of Jury
Trial.
|
58
|
Section 10.11
Specific Performance.
|
58
|
Section 10.12
Counterparts.
|
59
|
Β
EXHIBITS
Β
Exhibit
AΒ Β Β Form of Certificate of
Designations
Β
Β
Β
Β
Β
Β
Β
Β
This
Share Exchange Agreement (this βAgreementβ), dated as of April
21, 2020, is entered into among Singapore eDevelopment Ltd., a
Singapore corporation, company no. 200916763W having its office at
0 Xxxxxxx Xxxxxxxxx #00-00X, Xxxxxx Xxxxx Xxx, Xxxxxxxxx 000000
(βSEDβ),
Global BioMedical Pte Ltd.,
a Singapore corporation, company no. 201707501G having its office
at 0 Xxxxxxx Xxxxxxxxx #00-00X, Xxxxxx Xxxxx Xxx, Xxxxxxxxx 000000
(the βSellerβ),
Document Security Systems,
Inc., a New York corporation, having its office at 000 Xxxxx
Xxxx Xxxx, Xxxxx 000, Xxxxxxxxx, XX 00000 (βDSSβ) and DSS BioHealth Security Inc., a Nevada
corporation, having its office at 000 Xxxxx Xxxx Xxxx, Xxxxx 000,
Xxxxxxxxx, XX 00000 (the βBuyerβ). Each of SED, Seller, DSS
and Buyer is referred to herein as a βPartyβ and they are referred to
collectively as the βParties.β
Β
RECITALS
Β
WHEREAS, Seller
owns all of the issued and outstanding shares of common stock, par
value $0.001 per share (the βImpactΒ Sharesβ), of Impact BioMedical Inc., a Nevada
corporation, having its office at 0000 Xxxxxxxxxx Xxxx Xxxxx 000
Xxxxxxxx, XX 00000 (the βCompanyβ); and
Β
WHEREAS, SED owns
all of the issued and outstanding shares of Seller;
and
Β
WHEREAS, Seller
wishes to sell to Buyer, and Buyer wishes to purchase from Seller,
the Impact Shares, subject to the terms and conditions set forth
herein;
Β
NOW,
THEREFORE, in consideration of the mutual covenants and agreements
hereinafter set forth and for other good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties hereto agree as follows:
Β
ARTICLE I
DEFINITIONS
Β
Β
βAcquisition Proposalβ has the
meaning set forth in Section 5.03(a).
Β
βActionβ means any claim, action,
cause of action, demand, lawsuit, arbitration, inquiry, audit,
notice of violation, proceeding, litigation, citation, summons,
subpoena or investigation of any nature, civil, criminal,
administrative, regulatory or otherwise, whether at law or in
equity.
Β
βAffiliateβ of a Person means any
other Person that directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common
control with, such Person. The term βcontrolβ
(including the terms βcontrolled byβ and βunder
common control withβ) means the possession, directly or
indirectly, of the power to direct or cause the direction of the
management and policies of a Person, whether through the ownership
of voting securities, by contract or otherwise.
Β
βAgreed Valueβ has the meaning set
forth in Section 2.02(a)
Β
βAgreementβ has the meaning set
forth in the preamble.
Β
βAllocation Scheduleβ has the
meaning set forth in Section 6.05(b).
Β
Β
1
Β
βAncillary Documentsβ means the
Certificate of Designations.
Β
βAnnual Financial Statementsβ has
the meaning set forth in Section 3.07(a).
Β
βBalance Sheetβ has the meaning
set forth in Section 3.07(a).
Β
βBalance Sheet Dateβ has the
meaning set forth in Section 3.07(a).
Β
βBasketβ has the meaning set forth
in Section 8.04(a).
Β
βBenefit Planβ has the meaning set
forth in Section 3.22(a).
Β
βBusiness Dayβ means any day
except Saturday, Sunday or any other day on which commercial banks
located in New York, New York, are authorized or required by Law to
be closed for business.
Β
βBusiness Privacy and Data Security
Policiesβ means all of Sellerβs past or present,
internal or public-facing policies, notices, and statements
concerning the privacy, security, or Processing of Personal
Information in the conduct of the Business.
Β
βBuyerβ has the meaning set forth
in the preamble.
Β
βBuyer Indemniteesβ has the
meaning set forth in Section 8.02.
Β
βBuyerβs Accountantsβ means
Freed Xxxxxx CPAs, P.C.
Β
βCapβ has the meaning set forth in
Section 8.04(a).
Β
βCERCLAβ means the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as
amended by the Superfund Amendments and Reauthorization Act of
1986, 42 U.S.C. §§ 9601 et seq.
Β
βCertificate of Designationsβ has
the meaning set forth in Section 2.02(b)(ii).
Β
βClosingβ has the meaning set
forth in Section 2.05.
Β
βClosing Dateβ has the meaning set
forth in Section 2.05.
Β
βCodeβ means the Internal Revenue
Code of 1986, as amended.
Β
βCommon Stockβ has the meaning set
forth in Section 3.03(a).
Β
βCompanyβ has the meaning set
forth in the recitals.
Β
βCompany Groupβ means the Company
and each Subsidiary.
Β
βCompany Intellectual Propertyβ
means all Intellectual Property that is owned by the Company
Group.
Β
βCompany IP Agreementsβ means all
licenses, sublicenses, consent to use agreements, settlements,
coexistence agreements, covenants not to xxx, waivers, releases,
permissions and other Contracts, whether written or oral, relating
to Intellectual Property to which a member of the Company Group is
a party, beneficiary or otherwise bound.
Β
Β
2
Β
βCompany IP Registrationsβ means
all Company Intellectual Property that is subject to any issuance,
registration or application by or with any Governmental Authority
or authorized private registrar in any jurisdiction, including
issued patents, registered trademarks, domain names and copyrights,
and pending applications for any of the foregoing.
Β
βCompany IT Systemsβ means
all computer software, computer hardware, servers, networks,
platforms, peripherals, and similar or related items of automated,
computerized, or other information technology (IT) networks and
systems (including telecommunications networks and systems for
voice, data and video) owned, leased, licensed, or used (including
through cloud-based or other third-party service providers) by the
Company Group.
Β
βCompany Material Adverse Effectβ
means any event, occurrence, fact, condition or change that is, or
could reasonably be expected to become, individually or in the
aggregate, materially adverse to (a) the business, results of
operations, condition (financial or otherwise), assets or prospects
of the Company Group taken as a whole, or (b) the ability of Seller
and SED to consummate the transactions contemplated hereby on a
timely basis.
Β
βContractsβ means all contracts,
leases, deeds, mortgages, licenses, instruments, notes,
commitments, undertakings, indentures, joint ventures and all other
agreements, commitments and legally binding arrangements, whether
written or oral.
Β
βCurrent Liabilitiesβ means
accounts payable, accrued Taxes and accrued expenses, but excluding
payables to any of the Companyβs Affiliates, directors,
employees, officers or stockholders and any of their respective
Affiliates, deferred Tax liabilities, Transaction Expenses and the
current portion of any Indebtedness of the Company, determined in
accordance with GAAP applied using the same accounting methods,
practices, principles, policies and procedures, with consistent
classifications, judgments and valuation and estimation
methodologies that were used in the preparation of the Annual
Financial Statements for the most recent fiscal year end as if such
accounts were being prepared and audited as of a fiscal year
end.
Β
βDirect Claimβ has the meaning set
forth in Section 8.05(c).
Β
βDisclosure Schedulesβ means the
Disclosure Schedules delivered by Seller and SED and by Buyer and
DSS concurrently with the execution and delivery of this
Agreement.
Β
βDollars or $β means the lawful
currency of the United States of America.
Β
βDSSβ has the meaning set forth in
the preamble.
Β
Β βDSS
Common Sharesβ has the meaning set forth in Section
2.02(b)(i).
Β
βDSS Material Adverse Effectβ
means any event, occurrence, fact, condition or change that is, or
could reasonably be expected to become, individually or in the
aggregate, materially adverse to (a) the business, results of
operations, condition (financial or otherwise), assetsΒ or prospects of DSS
and its subsidiaries taken as a whole, or (b) the ability of Buyer
and DSS to consummate the transactions contemplated hereby on a
timely basis.
Β
βDSS Preferred Sharesβ has the
meaning set forth in Section 2.02(b)(ii).
Β
βDSS Proxy Filing Dateβ means the
date on which DSS first files with the SEC the preliminary DSS
Proxy Statement.
Β
Β
3
Β
Β
βDSSΒ Proxy Statementβ means the notice
of meeting and proxy statement, together with any supplements and
other disclosure documents related thereto, to be drafted by DSS
and its counsel and sent to holders of DSS common stock in
connection with the DSS Stockholdersβ Meeting.
Β
βDSS Sharesβ has the meaning set
forth in Section 2.02(b)(ii).
Β
βDSS Stockholdersβ Meetingβ
means the meeting of the holders of DSS common stock to consider
and vote on the transactions contemplated by this Agreement, and
any postponement or adjournment thereof.
Β
βEncumbranceβ means any charge,
claim, community property interest, pledge, condition, equitable
interest, lien (statutory or other), option, security interest,
mortgage, easement, encroachment, right of way, right of first
refusal, or restriction of any kind, including any restriction on
use, voting, transfer, receipt of income or exercise of any other
attribute of ownership.
Β
βEnvironmental Attributesβ means
any emissions and renewable energy credits, energy conservation
credits, benefits, offsets and allowances, emission reduction
credits or words of similar import or regulatory effect (including
emissions reduction credits or allowances under all applicable
emission trading, compliance or budget programs, or any other
federal, state or regional emission, renewable energy or energy
conservation trading or budget program) that have been held,
allocated to or acquired for the development, construction,
ownership, lease, operation, use or maintenance of any member of
the Company Group as of: (i) the date of this Agreement; and (ii)
future years for which allocations have been established and are in
effect as of the date of this Agreement.
Β
βEnvironmental Claimβ means any
Action, Governmental Order, lien, fine, penalty, or, as to each,
any settlement or judgment arising therefrom, by or from any Person
alleging liability of whatever kind or nature (including liability
or responsibility for the costs of enforcement proceedings,
investigations, cleanup, governmental response, removal or
remediation, natural resources damages, property damages, personal
injuries, medical monitoring, penalties, contribution,
indemnification and injunctive relief) arising out of, based on or
resulting from: (a) the presence, Release of, or exposure to, any
Hazardous Materials; or (b) any actual or alleged non-compliance
with any Environmental Law or term or condition of any
Environmental Permit.
Β
βEnvironmental Lawβ means any
applicable Law, and any Governmental Order or binding agreement
with any Governmental Authority: (a) relating to pollution (or the
cleanup thereof) or the protection of natural resources, endangered
or threatened species, human health or safety, or the environment
(including ambient air, soil, surface water or groundwater, or
subsurface strata); or (b) concerning the presence of, exposure to,
or the management, manufacture, use, containment, storage,
recycling, reclamation, reuse, treatment, generation, discharge,
transportation, processing, production, disposal or remediation of
any Hazardous Materials. The term βEnvironmental Lawβ
includes, without limitation, the following (including their
implementing regulations and any state analogs): the Comprehensive
Environmental Response, Compensation, and Liability Act of 1980, as
amended by the Superfund Amendments and Reauthorization Act of
1986, 42 U.S.C. §§ 9601 et seq.; the Solid Waste Disposal
Act, as amended by the Resource Conservation and Recovery Act of
1976, as amended by the Hazardous and Solid Waste Amendments of
1984, 42 U.S.C. §§ 6901 et seq.; the Federal Water
Pollution Control Act of 1972, as amended by the Clean Water Act of
1977, 33 U.S.C. §§ 1251 et seq.; the Toxic Substances
Control Act of 1976, as amended, 15 U.S.C. §§ 2601 et
seq.; the Emergency Planning and Community Right-to-Know Act of
1986, 42 U.S.C. §§ 11001 et seq.; the Clean Air Act of
1966, as amended by the Clean Air Act Amendments of 1990, 42 U.S.C.
§§ 7401 et seq.; and the Occupational Safety and Health
Act of 1970, as amended, 29 U.S.C. §§ 651 et
seq.
Β
Β
4
Β
Β
βEnvironmental Noticeβ means any
written directive, notice of violation or infraction, or notice
respecting any Environmental Claim relating to actual or alleged
non-compliance with any Environmental Law or any term or condition
of any Environmental Permit.
Β
βEnvironmental Permitβ means any
Permit, letter, clearance, consent, waiver, closure, exemption,
decision or other action required under or issued, granted, given,
authorized by or made pursuant to Environmental Law.
Β
βERISAβ means the Employee
Retirement Income Security Act of 1974, as amended, and the
regulations promulgated thereunder.
Β
βERISA Affiliateβ means all
employers (whether or not incorporated) that would be treated
together with the Company or any of its Affiliates as a
βsingle employerβ within the meaning of Section 414 of
the Code or Section 4001 of ERISA.
Β
βExchange Actβ means the U.S.
Securities Exchange Act of 1934, as amended.
Β
βFDAβ has the meaning set forth in
Section 3.19(c)
Β
βFinancial Statementsβ has the
meaning set forth in Section 3.07(a).
Β
βGAAPβ means United States
generally accepted accounting principles in effect from time to
time.
Β
βGovernment Contractsβ has the
meaning set forth in Section 3.10(a)(viii).
Β
βGovernmental Authorityβ means any
federal, state, local or foreign government or political
subdivision thereof, or any agency or instrumentality of such
government or political subdivision, or any self-regulated
organization or other non-governmental regulatory authority or
quasi-governmental authority (to the extent that the rules,
regulations or orders of such organization or authority have the
force of Law), or any arbitrator, court or tribunal of competent
jurisdiction, or any securities exchange on which the securities of
the relevant Party are listed or traded.
Β
βGovernmental Orderβ means any
order, writ, judgment, injunction, decree, stipulation,
determination or award entered by or with any Governmental
Authority.
Β
βHazardous Materialsβ means: (a)
any material, substance, chemical, waste, product, derivative,
compound, mixture, solid, liquid, mineral or gas, in each case,
whether naturally occurring or manmade, that is hazardous, acutely
hazardous, toxic, or words of similar import or regulatory effect
under Environmental Laws; and (b) any petroleum or
petroleum-derived products, radon, radioactive materials or wastes,
asbestos in any form, lead or lead-containing materials, urea
formaldehyde foam insulation, and polychlorinated
biphenyls.
Β
βHealth Care Lawsβ has the meaning
set forth in Section 3.19(c).
Β
βImpactΒ Sharesβ has the meaning set forth
in the recitals.
Β
βImpact Valueβ has the meaning set
forth in Section 7.02(c).
Β
βIndebtednessβ means, without
duplication and with respect to the Company Group, all (a)
indebtedness for borrowed money; (b) obligations for the deferred
purchase price of property or services, (c) long or short-term
obligations evidenced by notes, bonds, debentures or other similar
instruments; (d) obligations under any interest rate, currency swap
or other hedging agreement or arrangement; (e) capital lease
obligations; (f) reimbursement obligations under any letter of
credit, bankerβs acceptance or similar credit transactions;
(g) guarantees made by a member of the Company Group on behalf of
any third party in respect of obligations of the kind referred to
in the foregoing clauses (a) through (f); and (h) any unpaid
interest, prepayment penalties, premiums, costs and fees that would
arise or become due as a result of the prepayment of any of the
obligations referred to in the foregoing clauses (a) through
(g).
Β
Β
5
Β
βIndemnified Partyβ has the
meaning set forth in Section 8.05.
Β
βIndemnifying Partyβ has the
meaning set forth in Section 8.05.
Β
βIndependent Accountantβ has the
meaning set forth in Section 6.01(c).
Β
βInsurance Policiesβ has the
meaning set forth in Section 3.17.
Β
βIntellectual Propertyβ means any
and all rights in, arising out of, or associated with any of the
following in any jurisdiction throughout the world: (a) issued
patents and patent applications (whether provisional or
non-provisional), including divisionals, continuations,
continuations-in-part, substitutions, reissues, reexaminations,
extensions, or restorations of any of the foregoing, and other
Governmental Authority-issued indicia of invention ownership
(including certificates of invention, xxxxx patents, and patent
utility models) (βPatentsβ); (b) trademarks,
service marks, brands, certification marks, logos, trade dress,
trade names, and other similar indicia of source or origin,
together with the goodwill connected with the use of and symbolized
by, and all registrations, applications for registration, and
renewals of, any of the foregoing (βTrademarksβ); (c) copyrights and
works of authorship, whether or not copyrightable, and all
registrations, applications for registration, and renewals of any
of the foregoing (βCopyrightsβ); (d) internet domain
names and social media account or user names (including
βhandlesβ), whether or not Trademarks, all associated
web addresses, URLs, websites and web pages, social media sites and
pages, and all content and data thereon or relating thereto,
whether or not Copyrights; (e) mask works, and all registrations,
applications for registration, and renewals thereof; (f) industrial
designs, and all Patents, registrations, applications for
registration, and renewals thereof; (g) trade secrets, know-how,
inventions (whether or not patentable), discoveries, improvements,
technology, business and technical information, databases, data
compilations and collections, tools, methods, processes,
techniques, and other confidential and proprietary information and
all rights therein (βTrade
Secretsβ); (h) computer programs, operating systems,
applications, firmware, and other code, including all source code,
object code, application programming interfaces, data files,
databases, protocols, specifications, and other documentation
thereof; (i) rights of publicity; and (j) all other intellectual or
industrial property and proprietary rights.
Β
βInterim Balance Sheetβ has the
meaning set forth in Section 3.07(a).
Β
βInterim Balance Sheet Dateβ has
the meaning set forth in Section 3.07(a).
Β
βInterim Financial Statementsβ has
the meaning set forth in Section 3.07(a).
Β
βKnowledge of Seller or Sellerβs
Knowledgeβ or any other similar knowledge
qualification, means the actual or constructive knowledge of any
director or officer of SED, Seller or the Company, after due
inquiry.
Β
βLawβ means any statute, law,
ordinance, regulation, rule, code, order, constitution, treaty,
common law, judgment, decree, other requirement or rule of law of
any Governmental Authority.
Β
βLiabilitiesβ has the meaning set
forth in Section 3.08.
Β
βLicensed Intellectual
Propertyβ means all Intellectual Property in which a
member of the Company Group holds any rights or interests granted
by other Persons, including Seller or any of its
Affiliates.
Β
Β
6
Β
βLossesβ means losses, damages,
liabilities, deficiencies, Actions, judgments, interest, awards,
penalties, fines, costs or expenses of whatever kind, including
reasonable attorneysβ fees and the cost of enforcing any
right to indemnification hereunder and the cost of pursuing any
insurance providers; provided,
however, that βLossesβ shall not include
punitive damages, except to the extent actually awarded to a
Governmental Authority or other third party.
Β
βMaterial Contractsβ has the
meaning set forth in Section 3.10(a).
Β
βMoney Laundering Lawsβ has the
meaning set forth in Section 3.24.
Β
βPartyβ has the meaning set forth
in the preamble.
Β
βPCAOBβ means the United States
Public Company Accounting Oversight Board.
Β
βPermitsβ means all permits,
licenses, franchises, approvals, authorizations, consents,
registrations, certificates, variances and similar rights obtained,
or required to be obtained, from Governmental
Authorities.
Β
βPermitted Encumbrancesβ has the
meaning set forth in Section 3.11(a).
Β
βPersonβ means an individual,
corporation, partnership, joint venture, limited liability company,
Governmental Authority, unincorporated organization, trust,
association or other entity.
Β
βPersonal Informationβ means any
information that identifies or, alone or in combination with any
other information, could reasonably be used to identify, locate, or
contact a natural Person, including name, street address, telephone
number, email address, identification number issued by a
Governmental Authority, credit card number, bank information,
customer or account number, online identifier, device identifier,
IP address, browsing history, search history, or other website,
application, or online activity or usage data, location data,
biometric data, medical or health information, or any other
information that is considered βpersonally identifiable
information,β βpersonal information,β or
βpersonal dataβ under applicable Law, and all data
associated with any of the foregoing that are or could reasonably
be used to develop a profile or record of the activities of a
natural Person across multiple websites or online services, to
predict or infer the preferences, interests, or other
characteristics of a natural Person, or to target advertisements or
other content to a natural Person.
Β
βPlatform Agreementsβ has the
meaning set forth in Section 3.12(h).
Β
βPost-Closing Tax Periodβ means
any taxable period beginning after the Closing Date and, with
respect to any taxable period beginning before and ending after the
Closing Date, the portion of such taxable period beginning after
the Closing Date.
Β
βPost-Closing Taxesβ means Taxes
of the Company Group for any Post-Closing Tax Period.
Β
βPre-Closing Tax Periodβ means any
taxable period ending on or before the Closing Date and, with
respect to any taxable period beginning before and ending after the
Closing Date, the portion of such taxable period ending on and
including the Closing Date.
Β
βPre-Closing Taxesβ means Taxes of
the Company Group for any Pre-Closing Tax Period.
Β
Β
7
Β
Β
βPrivacy Lawsβ means all
applicable Laws, Governmental Orders, and binding guidance issued
by any Governmental Authority concerning the privacy, security, or
Processing of Personal Information (including Laws of jurisdictions
where Personal Information was collected), including, as
applicable, data breach notification Laws, consumer protection
Laws, Laws concerning requirements for website and mobile
application privacy policies and practices, Social Security number
protection Laws, data security Laws, and Laws concerning email,
text message, or telephone communications. Without limiting the
foregoing, Privacy Laws include: the Federal Trade Commission Act,
the Telephone Consumer Protection Act, the Telemarketing and
Consumer Fraud and Abuse Prevention Act, the Controlling the
Assault of Non-Solicited Pornography and Marketing Act of 2003, the
Childrenβs Online Privacy Protection Act, the California
Consumer Privacy Act of 2018, the Computer Fraud and Abuse Act, the
Electronic Communications Privacy Act, the Fair Credit Reporting
Act, the Fair and Accurate Credit Transaction Act, the Health
Insurance Portability and Accountability Act of 1996, as amended
and supplemented by the Health Information Technology for Economic
and Clinical Health Act of the American Recovery and Reinvestment
Act of 2009, the Xxxxx-Xxxxx-Xxxxxx Act, the Family Educational
Rights and Privacy Act, the GDPR, and all other similar
international, federal, state, provincial, and local
Laws.
Β
βProcessingβ means any operation
performed on Personal Information, including the collection,
creation, receipt, access, use, handling, compilation, analysis,
monitoring, maintenance, storage, transmission, transfer,
protection, disclosure, destruction, or disposal of Personal
Information.
Β
βPurchase Priceβ has the meaning
set forth in Section 2.02.
Β
βReal Propertyβ means the real
property owned, leased or subleased by the Company Group, together
with all buildings, structures and facilities located
thereon.
Β
Β βReleaseβ
means any actual or threatened release, spilling, leaking, pumping,
pouring, emitting, emptying, discharging, injecting, escaping,
leaching, dumping, abandonment, disposing or allowing to escape or
migrate into or through the environment (including, without
limitation, ambient air (indoor or outdoor), surface water,
groundwater, land surface or subsurface strata or within any
building, structure, facility or fixture).
Β
βRepresentativeβ means, with
respect to any Person, any and all directors, officers, employees,
consultants, financial advisors, counsel, accountants and other
agents of such Person.
Β
βRestricted Businessβ means
biomedical sciences research and development for licensing and
distribution, in the areas of healthcare and consumer
products.
Β
βRestricted Periodβ has the
meaning set forth in Section 5.06(a).
Β
βSECβ means the United States
Securities and Exchange Commission.
Β
βSEC Reportsβ has the meaning set
forth in Section 4.08(a).
Β
βSecurities Actβ means the U.S.
Securities Act of 1933, as amended
Β
βSEDβ has the meaning set forth in
the preamble.
Β
βSED Meeting Circularβ means the
notice of meeting and circular, together with any supplements and
other disclosure documents related thereto, to be drafted by SED
and its counsel and sent to holders of SED stock in connection with
the SED Stockholdersβ Meeting.
Β
Β
8
Β
Β
βSED Circular Filing Dateβ means
the date on which SED first files with the Singapore Exchange the
SED Meeting Circular.
Β
βSED Stockholdersβ Meetingβ
means the extraordinary general meeting of the holders of SED stock
to consider and vote on the transactions contemplated by this
Agreement, and any postponement or adjournment
thereof.
Β
βSection 338(h)(10) Electionβ has
the meaning set forth in Section 6.05(a).
Β
βSellerβ has the meaning set forth
in the preamble.
Β
βSeller Indemniteesβ has the
meaning set forth in Section 8.03.
Β
βSellerβs Accountantsβ means
Xxxxxx, Xxxxx & Company, LLP.
Β
βStraddle Periodβ has the meaning
set forth in Section 6.04.
Β
βSubsidiaryβ has the meaning set
forth in Section 3.04.
Β
βSubsidiary Equity Interestsβ has
the meaning set forth in Section 3.04.
Β
βTaxesβ means all federal, state,
local, foreign and other income, gross receipts, sales, use,
production, ad valorem, transfer, franchise, registration, profits,
license, lease, service, service use, withholding, payroll,
employment, unemployment, estimated, excise, severance,
environmental, stamp, occupation, premium, property (real or
personal), real property gains, windfall profits, customs, duties
or other taxes, fees, assessments or charges of any kind
whatsoever, together with any interest, additions or penalties with
respect thereto and any interest in respect of such additions or
penalties.
Β
βTax Claimβ has the meaning set
forth in Section 6.06.
Β
βTax Returnβ means any return,
declaration, report, claim for refund, information return or
statement or other document relating to Taxes, including any
schedule or attachment thereto, and including any amendment
thereof.
Β
βTerritoryβ means the United
States of America and its Territories and Possessions.
Β
βThird Party Claimβ has the
meaning set forth in Section 8.05(a).
Β
βTransaction Expensesβ means all
fees and expenses incurred by the Company, Seller or SED at or
prior to the Closing in connection with the preparation,
negotiation and execution of this Agreement and the Ancillary
Documents, and the performance and consummation of the transactions
contemplated hereby and thereby.
Β
Β βTransferβ
means, with respect to any DSS Share and the associated interest in
DSS, a transaction by which Seller assigns such DSS Share to
another Person who is or becomes a shareholder of DSS, and includes
a sale, assignment, gift, exchange or any other disposition by Law
or otherwise, including any transfer upon foreclosure of any
pledge, encumbrance, hypothecation or mortgage.
Β
βUnionβ has the meaning set forth
in Section 3.09(t).
Β
βValuation Reportβ has the meaning
set forth in Section 7.02(c).
Β
βWARN Actβ means the federal
Worker Adjustment and Retraining Notification Act of 1988, and
similar state, local and foreign laws related to plant closings,
relocations, mass layoffs and employment losses.
Β
Β
9
Β
Β
ARTICLE II
PURCHASE
AND SALE
Β
Section 2.01Β Purchase and Sale. Subject to the terms
and conditions set forth herein, at the Closing, Seller shall sell
to Buyer, and Buyer shall purchase from Seller, the Impact Shares,
free and clear of all Encumbrances, for the consideration specified
in Section 2.02.
Β
Β
(a)Β The aggregate
purchase price for the Impact Shares shall be the equivalent of
$50,000,000.00 (the βAgreed
Valueβ), payable as provided in paragraph (b) below,
and subject to adjustment pursuant to Section 2.04 below (the
βPurchase
Priceβ). In the event that a Section 338(h)(10)
election is made, the Parties agree to allocate the Purchase Price
for tax purposes as provided in Section 6.05(b).
Β
Β
(i)Β 14,500,000 newly
issued shares of the common stock, $0.02 par value per share, of
DSS (the βDSS Common
Sharesβ), nominally valued at $3,132,000, or $0.216
per share; and
Β
(ii)Β 46,868 (as adjusted
pursuant to Section 2.04(a) hereof, if applicable) newly issued
shares of a new series of perpetual convertible preferred stock of
DSS with a stated value of $46,868,000, or $1,000 per share,
convertible into shares of DSS common stock (the
βDSS Preferred
Sharesβ), having the designations, preferences and
rights set forth in the Certificate of Designations in the form
attached hereto as Exhibit A (the
βCertificate of
Designationsβ). (The DSS Preferred Shares and the DSS
Common Shares, and the additional shares of DSS Common stock issued
or issuable upon conversion of the DSS Preferred Shares, are
referred to as the βDSS
Shares.β)
Β
Section 2.03Β Transactions to be Effected at the
Closing.Β
Β
(a)Β At the Closing,
Buyer shall:
Β
(i)Β deliver to
Seller:
Β
(A)Β a duly executed
and authenticated certificate or certificates representing the DSS
Common Shares, free and clear of all Encumbrances, registered in
the name of the Seller;
Β
(B)Β a duly executed
and authenticated certificate or certificates representing the DSS
Preferred Shares, free and clear of all Encumbrances, registered in
the name of the Seller; and
Β
(C)Β the Ancillary
Documents and all other agreements, documents, instruments or
certificates required to be delivered by Buyer at or prior to the
Closing pursuant to Section 7.03 of this Agreement.
Β
Β
10
Β
Β
(b)Β At the Closing,
Seller shall deliver to Buyer:
Β
(i)Β stock certificates
evidencing the Impact Shares, free and clear of all Encumbrances,
duly endorsed in blank or accompanied by stock powers or other
instruments of transfer duly executed in blank, with all required
stock transfer tax stamps affixed thereto; and
Β
(ii)Β the Ancillary
Documents and all other agreements, documents, instruments or
certificates required to be delivered by Seller at or prior to the
Closing pursuant to Section 7.02 of this Agreement.
Β
Β
(a)Β Closing Adjustment. At the
Closing, the Purchase Price shall be adjusted in the following
manner:
Β
Β If
the Impact Value is less than the Agreed Value, then the number of
DSS Preferred Shares to be delivered to the Seller at Closing shall
be adjusted downwards in accordance with the formula
below.
Β
Number
of DSS Preferred Shares to be delivered to the Seller at Closing =
($46,868,000 β (Agreed Value β Impact
Value))/0.216).
Β
The
number of DSS Common Shares to be delivered to the Seller at
Closing will not change.
Β
(b)Β Indemnification Adjustment. At
Buyerβs sole option, by notification in writing to Seller,
any amounts payable to Buyer or any Buyer Indemnified Party under
ARTICLE VI or ARTICLE VIII hereof may be satisfied, in whole or in
part, by reducing the aggregate and per share stated value of the
DSS Preferred Shares by a dollar amount equal to such amounts so
payable, as further provided in the Certificate of
Designations.
Β
Section 2.05Β Closing. Subject to the terms and
conditions of this Agreement, the purchase and sale of the Impact
Shares contemplated hereby shall take place at a closing (the
βClosingβ) to
be held at 10:00 a.m., New York time, no later than two Business
Days after the last of the conditions to Closing set forth in
ARTICLE VII have been satisfied or waived (other than conditions
which, by their nature, are to be satisfied on the Closing Date),
at the offices of Sichenzia Xxxx Xxxxxxx LLP, 1185 Avenue of the
Xxxxxxxx, 00xx Xxxxx, Xxx Xxxx,
XX 00000, or remotely by exchange of documents and signatures (or
their electronic counterparts), or at such other time or on such
other date or at such other place as Seller and Buyer may mutually
agree upon in writing (the day on which the Closing takes place
being the βClosing
Dateβ).
Β
Section 2.06Β Withholding Tax. Buyer and the Company
shall be entitled to deduct and withhold from the Purchase Price
all Taxes that Buyer and the Company may be required to deduct and
withhold under any provision of Tax Law. All such withheld amounts
shall be treated as delivered to Seller hereunder.
Β
REPRESENTATIONS
AND WARRANTIES OF SELLER AND SED
Β
Except
as set forth in the correspondingly numbered Section of the
Disclosure Schedules (which will be delivered to Buyer and DSS on
or before the DSS Proxy Filing Date and shall be attached to and
become a part of this Agreement as of the DSS Proxy Filing Date),
each of SED and Seller, jointly and severally, represents and
warrants to each of Buyer and DSS that the statements contained in
this ARTICLE III will be true and correct as of the DSS Proxy
Filing Date.
Β
Section 3.01Β Organization and Authority of Seller.
Each of SED and Seller is a corporation duly organized, validly
existing and in good standing under the Laws of Singapore. Each of
SED and Seller has full corporate power and authority to enter into
this Agreement and the Ancillary Documents to which Seller is a
party, to carry out its obligations hereunder and thereunder and to
consummate the transactions contemplated hereby and thereby. The
execution and delivery by each of SED and Seller of this Agreement
and the Ancillary Documents to which it is a party, the performance
by each of SED and Seller of its obligations hereunder and
thereunder, and the consummation by each of SED and Seller of the
transactions contemplated hereby and thereby have been duly
authorized by all requisite corporate action on the part of SED or
Seller, as the case may be. This Agreement has been duly executed
and delivered by each of SED and Seller, and (assuming due
authorization, execution and delivery by the other Parties hereto)
this Agreement constitutes a legal, valid and binding obligation of
each of SED and Seller enforceable against it in accordance with
its terms. When each other Ancillary Documents to which each of SED
and Seller is a party has been duly executed and delivered by it
(assuming due authorization, execution and delivery by each other
Party thereto), such Ancillary Document will constitute a legal and
binding obligation of Seller enforceable against it in accordance
with its terms.
Β
Section 3.02Β Organization, Authority and Qualification of
the Company and Subsidiaries. The Company and each
Subsidiary is a corporation, limited liability company or other
business entity duly organized, validly existing and in good
standing under the Laws of the state of is formation and has full
corporate power and authority to own, operate or lease the
properties and assets now owned, operated or leased by it and to
carry on its business as it has been and is currently conducted.
Section 3.02
of the Disclosure
Schedules sets forth each jurisdiction in which the Company
and each Subsidiary is licensed or qualified to do business, and
the Company and each Subsidiary is duly licensed or qualified to do
business and is in good standing in each jurisdiction in which the
properties owned or leased by it or the operation of its business
as currently conducted makes such licensing or qualification
necessary. The execution and delivery by the Company of any
Ancillary Document to which the Company is a party, the performance
by the Company of its obligations hereunder and thereunder, and the
consummation by the Company of the transactions contemplated hereby
and thereby have been duly authorized by all requisite corporate
action on the part of the Company. When each other Ancillary
Document to which the Company is or will be a party has been duly
executed and delivered by Seller (assuming due authorization,
execution and delivery by each other party thereto), such Ancillary
Document will constitute a legal and binding obligation of the
Company enforceable against it in accordance with its terms. All
corporate actions to be taken by the Company in connection with
this Agreement and the Ancillary Documents will be duly authorized
on or prior to the Closing.
Β
Β
(a)Β The authorized capital stock of the
Company consists of 100,000,000 shares of common stock, par value
$0.001 (βCommon
Stockβ), of which 13,897,069 shares are issued and
outstanding and constitute the Impact Shares. All of the Impact
Shares have been duly authorized, are validly issued, fully paid
and non-assessable, and are owned of record and beneficially by
Seller, free and clear of all Encumbrances. Upon consummation of
the transactions contemplated by this Agreement, Buyer shall own
all of the Impact Shares, free and clear of all
Encumbrances.
Β
Β
11
Β
Β
(b)Β All of the Impact
Shares were issued in compliance with applicable Laws. None of the
Impact Shares were issued in violation of any agreement,
arrangement or commitment to which Seller or the Company is a party
or is subject to or in violation of any preemptive or similar
rights of any Person.
Β
(c)Β There are no
outstanding or authorized options, warrants, convertible securities
or other rights, agreements, arrangements or commitments of any
character relating to the capital stock of the Company or
obligating Seller or the Company to issue or sell any shares of
capital stock of, or any other interest in, the Company. The
Company does not have outstanding or authorized any stock
appreciation, phantom stock, profit participation or similar
rights. There are no voting trusts, stockholder agreements, proxies
or other agreements or understandings in effect with respect to the
voting or transfer of any of the Impact Shares.
Β
Β
(a)Β Section 3.04 of the Disclosure Schedules
lists each subsidiary of the Company (each, a βSubsidiaryβ), indicating the type
of legal entity, its jurisdiction of formation and the number and
type of shares or other equity or ownership interests thereof held
by the Company (the βSubsidiary Equity Interestsβ).
Except for the Subsidiaries listed in Section 3.04 of the Disclosure Schedules,
the Company does not own, directly or indirectly, any capital stock
or other equity securities of any corporation or have any direct or
indirect equity or ownership interest, including interests in
partnerships, limited liability companies and joint ventures, and
is not a general or limited partner in any partnership, a member of
any limited liability company or a co-venturer in any joint venture
or other business enterprise.
Β
(b)Β The Company owns,
directly or indirectly through another Subsidiary, beneficially and
of record, all of the outstanding Subsidiary Equity Interests of
each Subsidiary, free and clear of all Encumbrances. All of the
Subsidiary Equity Interests have been duly authorized, are validly
issued, fully paid and non-assessable.
Β
Section 3.05Β No
Conflicts; Consents. The execution, delivery and performance
by each of SED and Seller of this Agreement and the Ancillary
Documents to which it is a party, and the consummation of the
transactions contemplated hereby and thereby, do not and will not:
(a) conflict with or result in a violation or breach of, or default
under, any provision of the certificate of incorporation, by-laws
or other organizational documents of SED, Seller or any member of
the Company Group; (b) conflict with or result in a violation or
breach of any provision of any Law or Governmental Order applicable
to SED, Seller or any member of the Company Group; (c) except as
set forth in Section
3.05 of the
Disclosure Schedules, require the consent, notice or other
action by any Person under, conflict with, result in a violation or
breach of, constitute a default or an event that, with or without
notice or lapse of time or both, would constitute a default under,
result in the acceleration of or create in any party the right to
accelerate, terminate, modify or cancel any Contract to which SED,
Seller or any member of the Company Group is a party or by which
SED, Seller or any member of the Company Group is bound or to which
any of their respective properties and assets are subject
(including any Material Contract) or any Permit affecting the
properties, assets or business of any member of the Company Group ;
or (d) result in the creation or imposition of any Encumbrance
other than Permitted Encumbrances on any properties or assets of
any member of the Company Group. Except for the approvals,
confirmations and/or waivers from the Singapore Exchange Securities
Trading Limited and/or Hong Xxxxx Finance Limited as set forth in,
and except as otherwise set forth in, Section 3.05 of the Disclosure Schedules,
no consent, approval, Permit, Governmental Order, declaration or
filing with, or notice to, any Governmental Authority is required
by or with respect to SED, Seller or any member of the Company
Group in connection with the execution and delivery of this
Agreement and the Ancillary Documents and the consummation of the
transactions contemplated hereby and thereby.
Β
Β
12
Β
Β
Section 3.06Β SED Stockholder Approval. The approval
by the holders of SED common stock is the only vote of holders of
any class of DSS capital stock necessary to adopt and approve this
Agreement and the transactions contemplated hereby. The affirmative
vote of Persons holding at least a majority of the issued and
outstanding shares of SED common stock as of the record date for
the SED Stockholdersβ Meeting is the only vote of SED
stockholders required to approve this Agreement and the
transactions contemplated hereby. SEDβs board of directors,
by resolution duly adopted by the unanimous vote of the entire
board of directors at a meeting duly called and held, has (i)
determined that this Agreement and the transactions contemplated
hereby are advisable and are in the best interests of SED and its
stockholders, (ii) authorized and approved this Agreement and the
transactions contemplated hereby, (iii) directed that the this
Agreement and the transactions contemplated hereby be submitted for
consideration at the SED Stockholdersβ Meeting, and (iv)
recommended that its stockholders approve the this Agreement and
the transactions contemplated hereby.
Β
Section 3.07Β Financial
Statements; Accounting.
Β
(a)Β The unaudited consolidated financial
statements of the Company and its Subsidiaries consisting of the
consolidated balance sheet as at December 31 in each of the years
2019 and 2018 and the related consolidated statements of income and
retained earnings, stockholdersβ equity and cash flow for the
years then ended, including the notes thereto (the
βAnnual Financial
Statementsβ), and unaudited consolidated financial
statements consisting of the consolidated balance sheet as at March
31, 2020, and the related consolidated statements of income and
retained earnings, stockholdersβ equity and cash flow for the
three-month period then ended, including the notes thereto (the
βInterim Financial
Statementsβ and together with the Annual Financial
Statements, the βFinancial
Statementsβ) have been delivered to Buyer. The
Financial Statements have been prepared in accordance with GAAP
applied on a consistent basis throughout the period involved,
subject, in the case of the Interim Financial Statements, to normal
and recurring year-end adjustments (the effect of which will not be
materially adverse) and the absence of notes (that, if presented,
would not differ materially from those presented in the Annual
Financial Statements). The Financial Statements are based on the
books and records of the Company Group, and fairly present the
financial condition of the Company Group as of the respective dates
they were prepared and the results of the operations of the Company
Group for the periods indicated. The consolidated balance sheet of
the Company Group as of December 31, 2019, is referred to herein as
the βBalance
Sheetβ and the date thereof as the βBalance Sheet Dateβ and the
consolidated balance sheet of the Company Group as of March 31,
2020, is referred to herein as the βInterim Balance Sheetβ and the
date thereof as the βInterim
Balance Sheet Dateβ.
Β
(b)Β The Company and
its Subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (a) transactions
are executed in accordance with managementβs general or
specific authorizations, (b) transactions are recorded as necessary
to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (c) access to assets is
permitted only in accordance with managementβs general or
specific authorization, and (d) the recorded accountability for
assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any
differences.
Β
Section 3.08Β Undisclosed Liabilities. The Company
Group has no liabilities, obligations or commitments of any nature
whatsoever, asserted or unasserted, known or unknown, absolute or
contingent, accrued or unaccrued, matured or unmatured or otherwise
(βLiabilitiesβ), except (a) those
which are adequately reflected or reserved against in the Balance
Sheet as of the Balance Sheet Date, and (b) those which have been
incurred in the ordinary course of business consistent with past
practice since the Balance Sheet Date and which are not,
individually or in the aggregate, material in amount.
Β
Β
13
Β
Β
Section 3.09Β Absence of Certain Changes, Events and
Conditions. Since the Balance Sheet Date, and other than in
the ordinary course of business consistent with past practice,
there has not been, with respect to any member of the Company
Group, any:
Β
(a)Β event, occurrence
or development that has had, or could reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse
Effect;
Β
(b)Β amendment of the
charter, by-laws or other organizational documents of the
Company;
Β
(c)Β split, combination
or reclassification of any shares of its capital
stock;
Β
(d)Β issuance, sale or
other disposition of any of its capital stock, or grant of any
options, warrants or other rights to purchase or obtain (including
upon conversion, exchange or exercise) any of its capital
stock;
Β
(e)Β declaration or
payment of any dividends or distributions on or in respect of any
of its capital stock or redemption, purchase or acquisition of its
capital stock;
Β
(f)Β material change in
any method of accounting or accounting practice of the Company,
except as required by GAAP or as disclosed in the notes to the
Financial Statements;
Β
(g)Β material change in
its cash management practices and its policies, practices and
procedures with respect to collection of accounts receivable,
establishment of reserves for uncollectible accounts, accrual of
accounts receivable, inventory control, prepayment of expenses,
payment of trade accounts payable, accrual of other expenses,
deferral of revenue and acceptance of customer
deposits;
Β
(h)Β entry into any
Contract that would constitute a Material Contract;
Β
(i)Β incurrence,
assumption or guarantee of any indebtedness for borrowed money
except unsecured current obligations and Liabilities incurred in
the ordinary course of business consistent with past
practice;
Β
(j)Β transfer,
assignment, sale or other disposition of any of the assets shown or
reflected in the Balance Sheet or cancellation of any debts or
entitlements;
Β
(k)Β transfer or
assignment of or grant of any license or sublicense under or with
respect to any Company Intellectual Property or Company IP
Agreements;
Β
(l)Β abandonment or
lapse of or failure to maintain in full force and effect any
Company IP Registration, or failure to take or maintain reasonable
measures to protect the confidentiality or value of any Trade
Secrets included in the Company Intellectual Property;
Β
(m)Β material damage,
destruction or loss (whether or not covered by insurance) to its
property;
Β
Β
14
Β
Β
(n)Β any capital
investment in, or any loan to, any other Person;
Β
(o)Β acceleration,
termination, material modification to or cancellation of any
material Contract (including, but not limited to, any Material
Contract) to which any member of the Company Group is a party or by
which it is bound;
Β
(p)Β any material
capital expenditures;
Β
(q)Β imposition of any
Encumbrance upon any of any member of the Company Groupβs
properties, capital stock or assets, tangible or
intangible;
Β
(r)Β (i) grant of any
bonuses, whether monetary or otherwise, or increase in any wages,
salary, severance, pension or other compensation or benefits in
respect of its current or former employees, officers, directors,
independent contractors or consultants, other than as provided for
in any written agreements or required by applicable Law, (ii)
change in the terms of employment for any employee or any
termination of any employees for which the aggregate costs and
expenses exceed $50,000, or (iii) action to accelerate the vesting
or payment of any compensation or benefit for any current or former
employee, officer, director, independent contractor or
consultant;
Β
(s)Β hiring or
promoting any person except to fill a vacancy in the ordinary
course of business;
Β
(t)Β adoption, modification or termination
of any: (i) employment, severance, retention or other agreement
with any current or former employee, officer, director, independent
contractor or consultant, (ii) Benefit Plan or (iii) collective
bargaining or other agreement with a a union, works council or
labor organization (collectively, βUnionβ), in each case whether
written or oral;
Β
(u)Β any loan to (or
forgiveness of any loan to), or entry into any other transaction
with, any of its stockholders or current or former directors,
officers and employees;
Β
(v)Β entry into a new
line of business or abandonment or discontinuance of existing lines
of business;
Β
(w)Β adoption of any
plan of merger, consolidation, reorganization, liquidation or
dissolution or filing of a petition in bankruptcy under any
provisions of federal or state bankruptcy Law or consent to the
filing of any bankruptcy petition against it under any similar
Law;
Β
(x)Β purchase, lease or
other acquisition of the right to own, use or lease any property or
assets for an amount in excess of $10,000, individually (in the
case of a lease, per annum) or $100,000 in the aggregate (in the
case of a lease, for the entire term of the lease, not including
any option term), except for purchases of inventory or supplies in
the ordinary course of business consistent with past
practice;
Β
(y)Β acquisition by
merger or consolidation with, or by purchase of a substantial
portion of the assets or stock of, or by any other manner, any
business or any Person or any division thereof;
Β
(z)Β action by any
member of the Company Group to make, change or rescind any Tax
election, amend any Tax Return or take any position on any Tax
Return, take any action, omit to take any action or enter into any
other transaction that would have the effect of increasing the Tax
liability or reducing any Tax asset of Buyer in respect of any
Post-Closing Tax Period; or
Β
Β
15
Β
Β
(aa)Β any Contract to do
any of the foregoing, or any action or omission that would result
in any of the foregoing.
Β
Β
(a)Β Section 3.10(a) of the Disclosure Schedules
lists each of the following Contracts of any member of the Company
Group (such Contracts, together with all Contracts concerning the
occupancy, management or operation of any Real Property (including
without limitation, brokerage contracts) listed or otherwise
disclosed in Section
3.11(b) of the
Disclosure Schedules and all Company IP Agreements set forth
in Section 3.12(b)
of the Disclosure
Schedules, being βMaterial
Contractsβ):
Β
(i)Β each Contract
involving aggregate consideration in excess of $100,000 and which,
in each case, cannot be cancelled by the member of the Company
Group without penalty or without more than 90 daysβ
notice;
Β
(ii)Β all Contracts that
require any member of the Company Group to purchase its total
requirements of any product or service from a third party or that
contain βtake or payβ provisions;
Β
(iii)Β all Contracts that
provide for the indemnification by any member of the Company Group
of any Person or the assumption of any Tax, environmental or other
Liability of any Person;
Β
(iv)Β all Contracts that
relate to the acquisition or disposition of any business, a
material amount of stock or assets of any other Person or any real
property (whether by merger, sale of stock, sale of assets or
otherwise);
Β
(v)Β all broker,
distributor, dealer, manufacturerβs representative,
franchise, agency, sales promotion, market research, marketing
consulting and advertising Contracts to which any member of the
Company Group is a party;
Β
(vi)Β all employment
agreements and Contracts with independent contractors or
consultants (or similar arrangements) to which any member of the
Company Group is a party and which are not cancellable without
material penalty or without more than 90 daysβ
notice;
Β
(vii)Β except for
Contracts relating to trade receivables, all Contracts relating to
indebtedness (including, without limitation, guarantees) of any
member of the Company Group;
Β
(viii)Β all Contracts with any Governmental
Authority to which any member of the Company Group is a party
(βGovernment
Contractsβ);
Β
(ix)Β all Contracts that
limit or purport to limit the ability of any member of the Company
Group to compete in any line of business or with any Person or in
any geographic area or during any period of time;
Β
Β
16
Β
Β
(x)Β any Contracts to
which any member of the Company Group is a party that provide for
any joint venture, partnership or similar arrangement by any member
of the Company Group;
Β
(xi)Β all Contracts
between or among any member of the Company Group on the one hand
and Seller or any Affiliate of Seller (other than any member of the
Company Group) on the other hand;
Β
(xii)Β all collective
bargaining agreements or Contracts with any Union to which any
member of the Company Group is a party; and
Β
(xiii)Β any other Contract
that is material to the Company Group and not previously disclosed
pursuant to this Section 3.10.
Β
(b)Β Each Material
Contract is valid and binding on the Company Group member party
thereto in accordance with its terms and is in full force and
effect. None of the Company Group member or, to Sellerβs
Knowledge, any other party thereto is in breach of or default under
(or is alleged to be in breach of or default under), or has
provided or received any notice of any intention to terminate, any
Material Contract. No event or circumstance has occurred that, with
notice or lapse of time or both, would constitute an event of
default under any Material Contract or result in a termination
thereof or would cause or permit the acceleration or other changes
of any right or obligation or the loss of any benefit thereunder.
Complete and correct copies of each Material Contract (including
all modifications, amendments and supplements thereto and waivers
thereunder) have been made available to Buyer.
Β
Section 3.11Β Title to Assets; Real
Property.Β
Β
(a)Β No member of the Company Group owns
or has owned any Real Property. Each member of the Company Group
has good and valid title to, or a valid leasehold interest in, all
Real Property and personal property and other assets reflected in
the Annual Financial Statements or acquired after the Balance Sheet
Date, other than properties and assets sold or otherwise disposed
of in the ordinary course of business consistent with past practice
since the Balance Sheet Date. All such properties and assets
(including leasehold interests) are free and clear of Encumbrances
except for the following (collectively referred to as
βPermitted
Encumbrancesβ):
Β
(i)Β those items set
forth in Section
3.11(a) of the
Disclosure Schedules;
Β
(ii)Β liens for Taxes
not yet due and payable;
Β
(iii)Β mechanics,
carriersβ, workmenβs, repairmenβs or other like
liens arising or incurred in the ordinary course of business
consistent with past practice or amounts that are not delinquent
and which are not, individually or in the aggregate, material to
the business of the Company Group;
Β
(iv)Β easements, rights
of way, zoning ordinances and other similar encumbrances affecting
Real Property which are not, individually or in the aggregate,
material to the business of the Company Group; or
Β
Β
17
Β
Β
(v)Β liens arising
under original purchase price conditional sales contracts and
equipment leases with third parties entered into in the ordinary
course of business consistent with past practice which are not,
individually or in the aggregate, material to the business of the
Company Group.
Β
(b)Β Section 3.11(b) of the Disclosure Schedules
lists (i) the street address of each parcel of Real Property; (ii)
if such property is leased or subleased by any member of the
Company Group, the landlord under the lease, the rental amount
currently being paid, and the expiration of the term of such lease
or sublease for each leased or subleased property; and (iii) the
current use of such property. With respect to leased Real Property,
Seller has delivered or made available to Buyer true, complete and
correct copies of any leases affecting the Real Property. The
Company is not a sublessor or grantor under any sublease or other
instrument granting to any other Person any right to the
possession, lease, occupancy or enjoyment of any leased Real
Property. The use and operation of the Real Property in the conduct
of any member of the Company Groupβs business do not violate
in any material respect any Law, covenant, condition, restriction,
easement, license, permit or agreement. No material improvements
constituting a part of the Real Property encroach on real property
owned or leased by a Person other than any member of the Company
Group. There are no Actions pending nor, to the Sellerβs
Knowledge, threatened against or affecting the Real Property or any
portion thereof or interest therein in the nature or in lieu of
condemnation or eminent domain proceedings.
Β
(c)Β Condition and Sufficiency of Assets.
Except as set forth in Section 3.11(c) of the Disclosure Schedules,
the buildings, plants, structures, furniture, fixtures, machinery,
equipment, vehicles and other items of tangible personal property
of each member of the Company Group are structurally sound, are in
good operating condition and repair, and are adequate for the uses
to which they are being put, and none of such buildings, plants,
structures, furniture, fixtures, machinery, equipment, vehicles and
other items of tangible personal property is in need of maintenance
or repairs except for ordinary, routine maintenance and repairs
that are not material in nature or cost. The buildings, plants,
structures, furniture, fixtures, machinery, equipment, vehicles and
other items of tangible personal property currently owned or leased
by each member of the Company Group, together with all other
properties and assets of such entity, are sufficient for the
continued conduct of its business after the Closing in
substantially the same manner as conducted prior to the Closing and
constitute all of the rights, property and assets necessary to
conduct its business as currently conducted.
Β
Section 3.12Β Intellectual
Property.Β
Β
(a)Β Section 3.12(a) of the Disclosure Schedules
contains a correct, current, and complete list of: (i) all Company
IP Registrations, specifying as to each, as applicable: the title,
xxxx, or design; the record owner and inventor(s), if any; the
jurisdiction by or in which it has been issued, registered, or
filed; the patent, registration, or application serial number; the
issue, registration, or filing date; and the current status; (ii)
all unregistered Trademarks included in the Company Intellectual
Property; (iii) all proprietary Software of any member of the
Company Group; and (iv) all other Company Intellectual Property
used or held for us] in any member of the Company Groupβs
business as currently conducted and as proposed to be
conducted.
Β
(b)Β Section 3.12(b) of the Disclosure Schedules
contains a correct, current, and complete list of all Company IP
Agreements, specifying for each the date, title, and parties
thereto, and separately identifying the Company IP Agreements: (i)
under which any member of the Company Group is a licensor or
otherwise grants to any Person any right or interest relating to
any Company Intellectual Property; (ii) under which any member of
the Company Group is a licensee or otherwise granted any right or
interest relating to the Intellectual Property of any Person; and
(iii) which otherwise relate to any member of the Company
Groupβs ownership or use of Intellectual Property, in each
case identifying the Intellectual Property covered by such Company
IP Agreement. Seller has provided Buyer with true and complete
copies (or in the case of any oral agreements, a complete and
correct written description) of all Company IP Agreements,
including all modifications, amendments and supplements thereto and
waivers thereunder. Each Company IP Agreement is valid and binding
on the member of the Company Group party thereto in accordance with
its terms and is in full force and effect. Neither the member of
the Company Group party thereto nor any other party thereto is, or
is alleged to be, in breach of or default under, or has provided or
received any notice of breach of, default under, or intention to
terminate (including by non-renewal), any Company IP
Agreement.
Β
Β
18
Β
Β
(c)Β Except as set forth in Section 3.12(c) of the Disclosure Schedules,
the specified the member of the Company Group is the sole and
exclusive legal and beneficial, and with respect to the Company IP
Registrations, record, owner of all right, title, and interest in
and to the Company Intellectual Property, and has the valid and
enforceable right to use all other Intellectual Property used or
held for use in or necessary for the conduct of its business as
currently conducted and as proposed to be conducted, in each case,
free and clear of Encumbrances other than Permitted Encumbrances.
Each member of the Company Group has entered into binding, valid
and enforceable, written Contracts with each of its current and
former employees and independent contractors whereby such employee
or independent contractor (i) acknowledges a member of the Company
Groupβs exclusive ownership of all Intellectual Property
invented, created, or developed by such employee or independent
contractor within the scope of his or her employment or engagement
with the Company; (ii) grants to a member of the Company Group a
present, irrevocable assignment of any ownership interest such
employee or independent contractor may have in or to such
Intellectual Property; and (iii) irrevocably waives any right or
interest, including any moral rights, regarding any such
Intellectual Property, to the extent permitted by applicable Law.
Seller has provided Buyer with true and complete copies of all such
Contracts. All assignments and other instruments necessary to
establish, record, and perfect a member of the Company
Groupβs ownership interest in the Company IP Registrations
have been validly executed, delivered, and filed with the relevant
Governmental Authorities and authorized registrars.
Β
(d)Β Neither the
execution, delivery or performance of this Agreement, nor the
consummation of the transactions contemplated hereunder, will
result in the loss or impairment of, or require the consent of any
other Person in respect of, any member of the Company Groupβs
right to own or use any Company Intellectual Property or Licensed
Intellectual Property.
Β
(e)Β All of the Company
Intellectual Property and Licensed Intellectual Property is valid
and enforceable, and all Company IP Registrations are subsisting
and in full force and effect. The Company has taken all necessary
steps to maintain and enforce the Company Intellectual Property and
Licensed Intellectual Property and to preserve the confidentiality
of all Trade Secrets included in the Company Intellectual Property,
including by requiring all Persons having access thereto to execute
binding, written non-disclosure agreements. All required filings
and fees related to the Company IP Registrations have been timely
submitted with and paid to the relevant Governmental Authorities
and authorized registrars. Seller has provided Buyer with true and
complete copies of all file histories, documents, certificates,
office actions, correspondence, assignments, and other instruments
relating to the Company IP Registrations.
Β
(f)Β The conduct of any
member of the Company Groupβs business as currently and
formerly conducted and as proposed to be conducted, including the
use of the Company Intellectual Property and Licensed Intellectual
Property in connection therewith, and the products, processes and
services of any member of the Company Group have not infringed,
misappropriated or otherwise violated, and will not infringe,
misappropriate or otherwise violate, the Intellectual Property or
other rights of any Person. No Person has infringed,
misappropriated or otherwise violated any Company Intellectual
Property or Licensed Intellectual Property.
Β
(g)Β There are no
Actions (including any opposition, cancellation, revocation,
review, or other proceeding), whether settled, pending, or
threatened (including in the form of offers to obtain a license):
(i) alleging any infringement, misappropriation, or other violation
by any member of the Company Group of the Intellectual Property of
any Person; (ii) challenging the validity, enforceability,
registrability, patentability, or ownership of any Company
Intellectual Property or Licensed Intellectual Property or any
member of the Company Groupβs right, title, or interest in or
to any Company Intellectual Property or Licensed Intellectual
Property; or (iii) by any member of the Company Group or by the
owner of any Licensed Intellectual Property alleging any
infringement, misappropriation, or other violation by any Person of
the Company Intellectual Property or such Licensed Intellectual
Property. Neither Seller nor any member of the Company Group is
aware of any facts or circumstances that could reasonably be
expected to give rise to any such Action. The Company is not
subject to any outstanding or prospective Governmental Order
(including any motion or petition therefor) that does or could
reasonably be expected to restrict or impair the use of any Company
Intellectual Property or Licensed Intellectual
Property.
Β
Β
Β
19
Β
Β
(h)Β Section 3.12(h) of the Disclosure Schedules
contains a correct, current, and complete list of all social media
accounts used in any member of the Company Groupβs business.
The Company has complied with all terms of use, terms of service,
and other Contracts and all associated policies and guidelines
relating to its use of any social media platforms, sites, or
services (collectively, βPlatform Agreementsβ). There are
no Actions, whether settled, pending, or threatened, alleging any
(A) breach or other violation of any Platform Agreement by any
member of the Company Group; or (B) defamation, violation of
publicity rights of any Person, or any other violation by any
member of the Company Group in connection with its use of social
media.
Β
(i)Β All Company IT
Systems are in good working condition and are sufficient for the
operation of each member of the Company Groupβs business as
currently conducted and as proposed to be conducted, except where
any such failure would not have a Company Material Adverse Effect.
In the past three (3) years, there has been no (A) malfunction,
failure, continued substandard performance or other
impairmentΒ of the Company IT
Systems that has had or would have a Company Material Adverse
Effect, or (B) denial-of-service, or other cyber incident,
including any cyberattack of the Company IT Systems. Each member of
the Company Group has taken all commercially reasonable steps to
safeguard the confidentiality, availability, security, and
integrity of its Company IT Systems, including implementing and
maintaining appropriate backup, disaster recovery, and Software and
hardware support arrangements.
Β
Section 3.13Β Β Privacy
and Data Security.
Β
(a)Β The Company, and,
to Sellerβs Knowledge, all vendors, processors, or other
third parties acting for or on behalf of the company in connection
with the Processing of Personal Information or that otherwise have
been authorized to have access to Personal Information in the
possession or control of any member of the Company Group, comply
and at all times in the past three (3) years have complied, with
all of the following in the conduct of the Business: (A) Privacy
Laws; (B) rules of self-regulatory organizations, including the
Payment Card Industry Data Security Standard; (C) industry
standards, guidelines, and best practices, including the National
Institute of Standards and Technology (NIST) Cybersecurity
Framework; (D) the Business Privacy and Data Security Policies; and
(E) all obligations or restrictions concerning the privacy,
security, or Processing of Personal Information under any Contract
to which any member of the Company Group is a party or otherwise
bound as of the date hereof.
Β
(b)Β The execution,
delivery, and performance of this Agreement and the consummation of
the transactions contemplated hereby do not and will not: (A)
conflict with or result in a violation or breach of any Privacy
Laws or Business Privacy and Data Security Policies (as currently
existing or as existing at any time during which any Personal
Information was collected or Processed by or for any member of the
Company Group in the conduct of its business); or (B) require the
consent of or notice to any Person concerning such Personβs
Personal Information.
Β
(c)Β The Company has
posted to each of its websites and published or otherwise made
available in connection with each of its business products a
Business Privacy and Data Security Policy. No disclosure or
representation made or contained in any Business Privacy and Data
Security Policy has been inaccurate, misleading, deceptive, or in
violation of any Privacy Laws (including by containing any material
omission), and each member of the Company Groupβs practices
with respect to the Processing of Personal Information in the
Business conform, and at all times in the past three (3) years have
conformed, to the Business Privacy and Data Security Policies that
govern the use of such Personal Information. Seller has delivered
or made available to Buyer true, complete, and correct copies of
all Business Privacy and Data Security Policies that are currently
or in the pastΒ three (3) years were
in effect.
Β
Β
20
Β
Β
(d)Β In the
pastΒ three
(3) years, (A) to Sellerβs Knowledge, no Personal Information
in the possession or control of any member of the Company Group, or
held or Processed by any vendor, processor, or other third party
for or on behalf of any member of the Company Group, in the conduct
of the Business has been subject to any data or security breach or
unauthorized access, disclosure, use, loss, denial or loss of use,
alteration, destruction, compromise, or Processing (a
βSecurity
Incidentβ), and (B) no member of the Company Group has
notified and, to Sellerβs Knowledge, there have been no facts
or circumstances that would require any member of the Company Group
to notify, any Governmental Authority or other Person of any
Security Incident in the conduct of the Business.
Β
(e)Β In the
pastΒ three
(3) years, no member of the Company Group has received any notice,
request, claim, complaint, correspondence, or other communication
in writing from any Governmental Authority or other Person, and to
Sellerβs Knowledge there has not been any audit,
investigation, enforcement action (including any fines or other
sanctions), or other Action relating to, any actual, alleged, or
suspected Security Incident or violation of any Privacy Law
involving Personal Information in the possession or control of any
member of the Company Group, or held or Processed by any vendor,
processor, or other third party for or on behalf of any member of
the Company Group, in the conduct of the Business.
Β
(f)Β In the conduct of
the Business, each member of the Company Group has at all times in
the past three (3) years implemented and maintained, and required
all vendors, processors, and other third parties that Process any
Personal Information for or on behalf of any member of the Company
Group to implement and maintain, all security measures, plans,
procedures, controls, and programs, including written information
security programs, to (A) identify and address internal and
external risks to the privacy and security of Personal Information
in their possession or control; (B) implement, monitor, and improve
adequate and effective administrative, technical, and physical
safeguards to protect such Personal Information and the operation,
integrity, and security of its software, systems, applications, and
websites involved in the Processing of Personal Information; and
(C) provide notification in compliance with applicable Privacy Laws
in the case of any Security Incident.
Β
(g)Β In the past three
(3) years, the Company Group has /at least annually performed a
security risk assessment and a privacy impact assessment and
obtained an independent vulnerability assessment performed by a
recognized third-party audit firm. Each member of the Company Group
has used reasonable efforts to address and remediate all threats
and deficiencies identified in each such assessment. Section 3.13(g) of the Disclosure Schedules
sets forth a complete and accurate list of each such internal and
external assessment.
Β
Section 3.14Β Inventory. No member the Company Group
holds any inventory (whether raw materials, work-in-process or
finished goods).
Β
Section 3.15Β Accounts Receivable. No member the
Company Group has any accounts receivable.
Β
Section 3.16Β Customers and
Suppliers.Β
Β
(a)Β No member the
Company Group has any customer for goods or services.
Β
Β
21
Β
Β
(b)Β Except with respect
to any Material Contract set forth in Section 3.10(a) of the Disclosure Schedules,
no member the Company Group has paid consideration to any supplier
for goods or services rendered in an amount greater than or equal
to $100,000 for each of the two most recent fiscal
year.
Β
Section 3.17Β Insurance.Β Section 3.17 of the Disclosure Schedules
sets forth a true and complete list of all current policies or
binders of fire, liability, product liability, umbrella liability,
real and personal property, workersβ compensation, vehicular,
directorsβ and officersβ liability, fiduciary liability
and other casualty and property insurance maintained by Seller or
its Affiliates (including any member of the Company Group) and
relating to the assets, business, operations, employees, officers
and directors of any member of the Company Group (collectively, the
βInsurance
Policiesβ) and true and complete copies of such
Insurance Policies have been made available to Buyer. Such
Insurance Policies are in full force and effect and shall remain in
full force and effect following the consummation of the
transactions contemplated by this Agreement. Neither the Seller nor
any of its Affiliates (including any member of the Company Group)
has received any written notice of cancellation of, premium
increase with respect to, or alteration of coverage under, any of
such Insurance Policies. All premiums due on such Insurance
Policies have either been paid or, if due and payable prior to
Closing, will be paid prior to Closing in accordance with the
payment terms of each Insurance Policy. The Insurance Policies do
not provide for any retrospective premium adjustment or other
experience-based liability on the part of any member of the Company
Group. All such Insurance Policies (a) are valid and binding in
accordance with their terms; (b) are provided by carriers who are
financially solvent; and (c) have not been subject to any lapse in
coverage. Except as set forth on Section 3.17 of the Disclosure Schedules,
there are no claims related to the business of any member of the
Company Group pending under any such Insurance Policies as to which
coverage has been questioned, denied or disputed or in respect of
which there is an outstanding reservation of rights. None of Seller
or any of its Affiliates (including any member of the Company
Group) is in default under, or has otherwise failed to comply with,
in any material respect, any provision contained in any such
Insurance Policy. The Insurance Policies are of the type and in the
amounts customarily carried by Persons conducting a business
similar to the applicable member of the Company Group and are
sufficient for compliance with all applicable Laws and Contracts to
which the applicable member of the Company Group is a party or by
which it is bound.
Β
Β
(a)Β Except as set forth in Section 3.18(a) of the Disclosure Schedules,
there are no Actions pending or, to Sellerβs Knowledge,
threatened (a) against or by any member of the Company Group
affecting any of its properties or assets (or by or against Seller
or any Affiliate thereof and relating to any member of the Company
Group); or (b) against or by any member of the Company Group,
Seller or any Affiliate of Seller that challenges or seeks to
prevent, enjoin or otherwise delay the transactions contemplated by
this Agreement. No event has occurred or circumstances exist that
may give rise to, or serve as a basis for, any such
Action.
Β
(b)Β Except as set forth in Section 3.18(b) of the Disclosure Schedules,
there are no outstanding Governmental Orders and no unsatisfied
judgments, penalties or awards against or affecting any member of
the Company Group or any of its properties or assets. The Company
is in compliance with the terms of each Governmental Order set
forth in Section
3.18(b) of the
Disclosure Schedules. No event has occurred or circumstances
exist that may constitute or result in (with or without notice or
lapse of time) a violation of any such Governmental
Order.
Β
Β
Β
22
Β
Β
Section 3.19Β Compliance with Laws;
Permits.Β
Β
(a)Β Except as set forth in Section 3.19(a) of the Disclosure Schedules,
each member of the Company Group has complied, and is now
complying, with all Laws applicable to it or its business,
properties or assets.
Β
(b)Β All Permits required for each member
of the Company Group to conduct its business have been obtained by
it and are valid and in full force and effect. All fees and charges
with respect to such Permits as of the date hereof have been paid
in full. Section
3.19(b) of the
Disclosure Schedules lists all current Permits issued to any
member of the Company Group, including the names of the Permits and
their respective dates of issuance and expiration. No event has
occurred that, with or without notice or lapse of time or both,
would reasonably be expected to result in the revocation,
suspension, lapse or limitation of any Permit set forth in
Section 3.19(b)
of the Disclosure
Schedules.
Β
(c)Β Without limiting
the foregoing, each member of the Company Group holds, and is
operating in compliance with, all Permits and orders of the U.S.
Food and Drug Administration (the βFDAβ), its foreign counterparts.
Each member of the Company Group is in compliance with all
applicable federal, state, local and foreign laws, regulations,
orders and decrees applicable to the manufacture, distribution,
import and export of regulated products and component parts and
ingredients, except as would not reasonably be expected to have a
Company Material Adverse Effect. No member of the Company Group has
received any FDA Form 483, warning letter, untitled letter or other
correspondence or written notice from any Governmental Authority,
alleging or asserting noncompliance with the U.S. Food, Drug, and
Cosmetic Act (21 U.S.C. Β§ 301 et seq.) or comparable foreign
laws. No member of the Company Group has been notified, either
orally or in writing, by any Governmental Authority that a clinical
study has been put on hold or may be put on hold. Each member of
the Company Group, and to the Sellerβs Knowledge, each of
their respective directors, officers, employees and agents, is and
has been in material compliance with applicable health care laws,
including, to the extent applicable, without limitation, the U.S.
Food, Drug and Cosmetic Act (21 U.S.C. Β§ 301 et seq.), the
U.S. Anti-Kickback Statute (42 U.S.C.
§ 1320a-7b(b)), the U.S. Health Insurance
Portability and Accountability Act of 1996 (42 U.S.C. Β§ 1320d
et seq.), as amended by the U.S. Health Information Technology for
Economic and Clinical Health Act of 2009 (42 U.S.C. Β§ 17921 et
seq.), and the regulations promulgated pursuant to such laws, and
comparable state laws and foreign laws (collectively,
βHealth Care
Lawsβ), except, in each case, as would not reasonably
be expected to have a Company Material Adverse Effect. No member of
the Company Group has received written notice of any ongoing claim,
action, suit, proceeding, hearing, enforcement, investigation,
arbitration or other action from any Governmental Authority or
third party alleging that any product operation or activity is in
material violation of any Health Care Laws or any Permits. Each
member of the Company Group has filed, obtained, maintained or
submitted all reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments thereto
as required by any Health Care Laws or any Permits and all such
reports, documents, forms, notices, applications, records, claims,
submissions and supplements or amendments were complete, correct
and not misleading on the date filed (or were corrected or
supplemented by a subsequent submission), except where any of the
foregoing would not be reasonably expected to have a Company
Material Adverse Effect. No member of the Company Group has, either
voluntarily or involuntarily, initiated, conducted, or issued or
caused to be initiated, conducted or issued, any other notice or
action relating to any alleged product defect or violation and, to
the Sellerβs knowledge, no third party has initiated or
conducted any such notice or action relating to any member of the
Company Groupβs products in development.
Β
Β
23
Β
Β
(d)Β No member of the
Company Group is a party to any corporate integrity agreement,
deferred prosecution agreement, monitoring agreement, consent
decree, settlement order, or similar agreements, or has any
reporting obligations pursuant to any such agreement, plan or
correction or other remedial measure entered into with any
Governmental Authority.
Β
Β
(a)Β The Company is
currently and has been in compliance with all Environmental Laws
and has not, and the Seller has not, received from any Person any:
(i) Environmental Notice or Environmental Claim; or (ii) written
request for information pursuant to Environmental Law, which, in
each case, either remains pending or unresolved, or is the source
of ongoing obligations or requirements as of the Closing
Date.
Β
(b)Β The Company has obtained and is in
material compliance with all Environmental Permits (each of which
is disclosed in Section
3.20(b) of the
Disclosure Schedules) necessary for the ownership, lease,
operation or use of the business or assets of any member of the
Company Group and all such Environmental Permits are in full force
and effect and shall be maintained in full force and effect by
Seller through the Closing Date in accordance with Environmental
Law, and neither Seller nor any member of the Company Group is
aware of any condition, event or circumstance that might prevent or
impede, after the Closing Date, the ownership, lease, operation or
use of the business or assets of any member of the Company Group as
currently carried out. With respect to any such Environmental
Permits, Seller has undertaken, or will undertake prior to the
Closing Date, all measures necessary to facilitate transferability
of the same, and neither any member of the Company Group nor the
Seller is aware of any condition, event or circumstance that might
prevent or impede the transferability of the same, nor have they
received any Environmental Notice or written communication
regarding any material adverse change in the status or terms and
conditions of the same.
Β
(c)Β No real property
currently or formerly owned, operated or leased by any member of
the Company Group is listed on, or has been proposed for listing
on, the National Priorities List (or CERCLIS) under CERCLA, or any
similar state list.
Β
(d)Β There has been no
Release of Hazardous Materials in contravention of Environmental
Law with respect to the business or assets of any member of the
Company Group or any real property currently or formerly owned,
operated or leased by any member of the Company Group, and neither
any member of the Company Group nor Seller has received an
Environmental Notice that any real property currently or formerly
owned, operated or leased in connection with the business of any
member of the Company Group (including soils, groundwater, surface
water, buildings and other structure located on any such real
property) has been contaminated with any Hazardous Material which
could reasonably be expected to result in an Environmental Claim
against, or a violation of Environmental Law or term of any
Environmental Permit by, Seller or any member of the Company
Group.
Β
(e)Β Section 3.20(e) of the Disclosure Schedules
contains a complete and accurate list of all active or abandoned
aboveground or underground storage tanks owned or operated by any
member of the Company Group.
Β
(f)Β Section 3.20(f) of the Disclosure Schedules
contains a complete and accurate list of all off-site Hazardous
Materials treatment, storage, or disposal facilities or locations
used by any member of the Company Group or Seller and any
predecessors as to which any member of the Company Group or Seller
may retain liability, and none of these facilities or locations has
been placed or proposed for placement on the National Priorities
List (or CERCLIS) under CERCLA, or any similar state list, and
neither Seller nor any member of the Company Group has received any
Environmental Notice regarding potential liabilities with respect
to such off-site Hazardous Materials treatment, storage, or
disposal facilities or locations used by any member of the Company
Group or Seller.
Β
Β
24
Β
Β
(g)Β Neither Seller nor
any member of the Company Group has retained or assumed, by
contract or operation of Law, any liabilities or obligations of
third parties under Environmental Law.
Β
(h)Β Seller has provided or otherwise
made available to Buyer and listed in Section 3.20(h) of the Disclosure Schedules:
(i) any and all environmental reports, studies, audits, records,
sampling data, site assessments, risk assessments, economic models
and other similar documents with respect to the business or assets
of any member of the Company Group or any currently or formerly
owned, operated or leased real property which are in the possession
or control of the Seller or Company related to compliance with
Environmental Laws, Environmental Claims or an Environmental Notice
or the Release of Hazardous Materials; and (ii) any and all
material documents concerning planned or anticipated capital
expenditures required to reduce, offset, limit or otherwise control
pollution and/or emissions, manage waste or otherwise ensure
compliance with current or future Environmental Laws (including,
without limitation, costs of remediation, pollution control
equipment and operational changes).
Β
(i)Β Neither the Seller
nor any member of the Company Group is aware of or reasonably
anticipates, as of the Closing Date, any condition, event or
circumstance concerning the Release or regulation of Hazardous
Materials that might, after the Closing Date, prevent, impede or
materially increase the costs associated with the ownership, lease,
operation, performance or use of the business or assets of any
member of the Company Group as currently carried out.
Β
(j)Β Seller owns and controls all
Environmental Attributes (a complete and accurate list of which is
set forth in Section
3.20(j) of the
Disclosure Schedules) and has not entered into any contract
or pledge to transfer, lease, license, guarantee, sell, mortgage,
pledge or otherwise dispose of or encumber any Environmental
Attributes as of the date hereof. Neither Seller nor any member of
the Company Group is aware of any condition, event or circumstance
that might prevent, impede or materially increase the costs
associated with the transfer (if required) to Buyer of any
Environmental Attributes after the Closing Date.
Β
Section 3.21Β Employment Matters.Β
Β
Β
(b)Β Section 3.21(a) of the Disclosure Schedules
contains a list of all persons who are independent contractors or
consultants of each member of the Company Group as of the date
hereof, and sets forth for each such individual the following: (i)
name; (ii) title or position (including whether full-time or
part-time); (iii) retention date; (iv) current annual base
compensation rate or contract fee; (v) commission, bonus or other
incentive-based compensation; and (vi) a description of the fringe
benefits provided to each such individual as of the date hereof.
Except as set forth in Section 3.21(a) of the Disclosure Schedules,
as of the date hereof, all compensation, including wages,
commissions, bonuses, fees and other compensation, payable to all
independent contractors or consultants of any member of the Company
Group for services performed on or prior to the date hereof have
been paid in full (or accrued in full on the Interim Balance Sheet)
and there are no outstanding agreements, understandings or
commitments of any member of the Company Group with respect to any
compensation, commissions, bonuses or fees.
Β
Β
25
Β
Β
(c)Β No member of the
Company Group is, or has ever been, a party to, bound by, or
negotiating any collective bargaining agreement or other Contract
with a union, works council or labor organization (collectively,
βUnionβ), and
there is not, and has never been, any Union representing or
purporting to represent any employee of any member of the Company
Group.
Β
(d)Β The Company is and
has been in compliance with all applicable Laws pertaining to
consultants and independent contractors of any member of the
Company Group, including all Laws relating to labor relations,
equal opportunities, fair practices, discrimination, harassment,
retaliation, reasonable accommodation, disability rights or
benefits, immigration, wages, hours, overtime compensation, child
labor, hiring, promotion and termination, working conditions, meal
and break periods, privacy, health and safety, workersβ
compensation, leaves of absence, paid sick leave and unemployment
insurance. All individuals characterized and treated by any member
of the Company Group as independent contractors or consultants are
properly treated as independent contractors under all applicable
Laws. There are no Actions against any member of the Company Group
pending, or to the Sellerβs Knowledge, threatened to be
brought or filed, by or with any Governmental Authority or
arbitrator in connection with the employment of any current or
former consultant or independent contractor of any member of the
Company Group, including, without limitation, any charge,
investigation or claim relating to the Laws referred to in the
first sentence of this paragraph or any other employment related
matter arising under applicable Laws.
Β
Β
(a)Β Neither Seller or any of its
Affiliates nor any member of the Company Group currently has or
ever maintained, sponsored, contributed to, or required to be
contributed to, for the benefit of any current or former employee,
officer, director, retiree, independent contractor or consultant of
any member of the Company Group or any spouse or dependent of such
individual pension, benefit, retirement, compensation, employment,
consulting, profit-sharing, deferred compensation, incentive,
bonus, performance award, phantom equity, stock or stock-based,
change in control, retention, severance, vacation, paid time off
(PTO), medical, vision, dental, disability, welfare, Code Section
125 cafeteria, fringe benefit and other similar agreement, plan,
policy, program or arrangement (and any amendments thereto), in
each case whether or not reduced to writing and whether funded or
unfunded, including each βemployee benefit planβ within
the meaning of Section 3(3) of ERISA, whether or not tax-qualified
and whether or not subject to ERISA, (each, a βBenefit Planβ), nor is there any
Benefit Plan under which any member of the Company Group or any of
its ERISA Affiliates has or may have any Liability, or with respect
to which Buyer or any of its Affiliates would reasonably be
expected to have any Liability, contingent or
otherwise.
Β
(b)Β Β Except as set forth in
Section 3.22(b)
of the Disclosure
Schedules, neither the execution of this Agreement nor any
of the transactions contemplated by this Agreement will (either
alone or upon the occurrence of any additional or subsequent
events): (i) entitle any current or former director, officer,
independent contractor or consultant of any member of the Company
Group to severance pay or any other payment; (ii) accelerate the
time of payment, funding or vesting, or increase the amount of
compensation (including stock-based compensation) due to any such
individual; (iii) result in βexcess parachute paymentsβ
within the meaning of Section 280G(b) of the Code; or (vi) require
a βgross-upβ or other payment to any
βdisqualified individualβ within the meaning of Section
280G(c) of the Code.
Β
Β
26
Β
Β
(c)Β Each member of the
Company Group has complied with the WARN Act, and it has no plans
to undertake any action that would trigger the WARN
Act.
Β
Β
(a)Β All Tax Returns
required to be filed on or before the Closing Date by the Company
Group have been, or will be, timely filed. Such Tax Returns are, or
will be, true, complete and correct in all respects. All Taxes due
and owing by the Company Group (whether or not shown on any Tax
Return) have been, or will be, timely paid.
Β
(b)Β Each member of the
Company Group has withheld and paid each Tax required to have been
withheld and paid in connection with amounts paid or owing to any
employee, independent contractor, creditor, customer, shareholder
or other party, and complied with all information reporting and
backup withholding provisions of applicable Law.
Β
(c)Β No claim has been
made by any taxing authority in any jurisdiction where any member
of the Company Group does not file Tax Returns that it is, or may
be, subject to Tax by that jurisdiction.
Β
(d)Β No extensions or
waivers of statutes of limitations have been given or requested
with respect to any Taxes of any member of the Company
Group.
Β
(e)Β The amount of the
Company Groupβs Liability for unpaid Taxes for all periods
ending on or before March 31, 2020, does not, in the aggregate,
exceed the amount of accruals for Taxes (excluding reserves for
deferred Taxes) reflected on the Financial Statements. The amount
of the Company Groupβs Liability for unpaid Taxes for all
periods following the end of the recent period covered by the
Financial Statements shall not, in the aggregate, exceed the amount
of accruals for Taxes (excluding reserves for deferred Taxes) as
adjusted for the passage of time in accordance with the past custom
and practice of the Company Group (and which accruals shall not
exceed comparable amounts incurred in similar periods in prior
years).
Β
Β
(i)Β the taxable years
of any member of the Company Group as to which the applicable
statutes of limitations on the assessment and collection of Taxes
have not expired;
Β
(ii)Β those years for
which examinations by the taxing authorities have been completed;
and
Β
(iii)Β those taxable
years for which examinations by taxing authorities are presently
being conducted.
Β
(g)Β All deficiencies
asserted, or assessments made, against any member of the Company
Group as a result of any examinations by any taxing authority have
been fully paid.
Β
(h)Β No member of the
Company Group is a party to any Action by any taxing authority.
There are no pending or threatened Actions by any taxing
authority.
Β
Β
27
Β
Β
(i)Β Seller has
delivered to Buyer copies of all federal, state, local and foreign
income, franchise and similar Tax Returns, examination reports, and
statements of deficiencies assessed against, or agreed to by, any
member of the Company Group for all Tax periods ending after
December 31, 2016.
Β
(j)Β There are no
Encumbrances for Taxes (other than for current Taxes not yet due
and payable) upon the assets of any member of the Company
Group.
Β
(k)Β No member of the
Company Group is a party to, or bound by, any Tax indemnity, Tax
sharing or Tax allocation agreement.
Β
(l)Β No private letter
rulings, technical advice memoranda or similar agreement or rulings
have been requested, entered into or issued by any taxing authority
with respect to any member of the Company Group.
Β
(m)Β No member of the
Company Group has been a member of an affiliated, combined,
consolidated or unitary Tax group for Tax purposes. No member of
the Company Group has any Liability for Taxes of any Person (other
than the Company Group) under Treasury Regulations Section 1.1502-6
(or any corresponding provision of state, local or foreign Law), as
transferee or successor, by contract or otherwise.
Β
(n)Β No member of the
Company Group will be required to include any item of income in, or
exclude any item or deduction from, taxable income for any taxable
period or portion thereof ending after the Closing Date as a result
of:
Β
(i)Β any change in a
method of accounting under Section 481 of the Code (or any
comparable provision of state, local or foreign Tax Laws), or use
of an improper method of accounting, for a taxable period ending on
or prior to the Closing Date;
Β
(ii)Β an installment
sale or open transaction occurring on or prior to the Closing
Date;
Β
(iii)Β a prepaid amount
received on or before the Closing Date;
Β
(iv)Β any closing
agreement under Section 7121 of the Code, or similar provision of
state, local or foreign Law; or
Β
(v)Β any election under
Section 108(i) of the Code.
Β
(o)Β No member of the
Company Group has been a βdistributing corporationβ or
a βcontrolled corporationβ in connection with a
distribution described in Section 355 of the Code.
Β
(p)Β No member of the
Company Group is, nor has been, a party to, or a promoter of, a
βreportable transactionβ within the meaning of Section
6707A(c)(1) of the Code and Treasury Regulations Section 1.6011
4(b).
Β
(q)Β There is currently
no limitation on the utilization of net operating losses, capital
losses, built-in losses, tax credits or similar items of any member
of the Company Group under Sections 269, 382, 383, 384 or 1502 of
the Code and the Treasury Regulations thereunder (and comparable
provisions of state, local or foreign Law).
Β
Β
28
Β
Β
(r)Β Section 3.23(r) of the Disclosure
Schedules sets forth all foreign jurisdictions in which any member
of the Company Group is subject to Tax, is engaged in business or
has a permanent establishment. No member of the Company Group has
entered into a gain recognition agreement pursuant to Treasury
Regulations Section 1.367(a)-8. No member of the Company Group has
transferred an intangible the transfer of which would be subject to
the rules of Section 367(d) of the Code.
Β
(s)Β No property owned
by any member of the Company Group is (i) required to be treated as
being owned by another person pursuant to the so-called βsafe
harbor leaseβ provisions of former Section 168(f)(8) of the
Internal Revenue Code of 1954, as amended, (ii) subject to Section
168(g)(1)(A) of the Code, or (iii) subject to a disqualified
leaseback or long-term agreement as defined in Section 467 of the
Code.
Β
Section 3.24Β Money Laundering Laws. The operations
of each member of the Company Group are and have been conducted at
all times in compliance with applicable financial recordkeeping and
reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the money laundering statutes of
all U.S. and non-U.S. jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or
guidelines, issued, administered or enforced by any Governmental
Authority (collectively, the βMoney Laundering Lawsβ), and no
Proceeding involving any member of the Company Group with respect
to the Money Laundering Laws is pending or, to the Knowledge of
Seller, threatened.
Β
Section 3.25Β Foreign Corrupt Practices. Neither any
member of the Company Group nor, to Sellerβs Knowledge, any
director, officer, agent, employee or other Person acting on behalf
of any member of the Company Group has, in the course of its
actions for, or on behalf of, any member of the Company Group (a)
used any corporate or company funds for any unlawful contribution,
gift, entertainment or other unlawful expenses relating to
political activity; (b) made any direct or indirect unlawful
payment to any foreign or domestic government official or employee
from corporate funds; (c) violated or is in violation of any
provision of the U.S. Foreign Corrupt Practices Act of 1977, as
amended; or (d) made any unlawful bribe, rebate, payoff, influence
payment, kickback or other unlawful payment to any foreign or
domestic government official or employee.
Β
Section 3.26Β No Disagreements with Accountants and
Lawyers. To the Knowledge of Seller, there are no
disagreements of any kind, including but not limited to any
disagreements regarding fees owed for services rendered, presently
existing, or reasonably anticipated by Seller or any member of the
Company Group to arise, between any member of the Company Group and
the accountants and lawyers formerly or presently employed by any
member of the Company Group which could affect Seller or any member
of the Company Groupβs ability to perform any of its
obligations under this Agreement, and each member of the Company
Group is current with respect to any fees owed to its accountants
and lawyers. No independent accountant who was previously engaged
as the principal accountant to audit the any member of the Company
Groupβs financial statements has resigned (or indicated it
has declined to stand for re-election after the completion of the
current audit) or was dismissed, and there were no disagreements
with the accountant on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or
procedure, which disagreement(s), if not resolved to the
satisfaction of the accountant, would have caused it to make
reference to the subject matter of the disagreement(s) in
connection with its report.
Β
Section 3.27Β Books and Records. The minute books and
stock record books of each member of the Company Group, all of
which have been made available to Buyer, are complete and correct
and have been maintained in accordance with sound business
practices. The minute books of each member of the Company Group
contain accurate and complete records of all meetings, and actions
taken by written consent of, the stockholders, the board of
directors (or other governing body) and any committees thereof, and
no meeting, or action taken by written consent, of any such
stockholders, board of directors (or other governing body) or
committee has been held for which minutes have not been prepared
and are not contained in such minute books. At the Closing, all of
those books and records will be in the possession of the
Company.
Β
Β
29
Β
Β
Section 3.28Β Brokers. No broker, finder or
investment banker is entitled to any brokerage, finderβs or
other fee or commission in connection with the transactions
contemplated by this Agreement or other Ancillary Document based
upon arrangements made by or on behalf of Seller.
Β
Section 3.29Β Investment
Representations
Β
(a)Β Investment Purpose. Seller
understands and agrees that the consummation of this Agreement
including the delivery of the DSS Shares to Seller in exchange for
the Impact Shares as contemplated hereby may constitute the offer
and sale of securities under the Securities Act and applicable
state securities laws and that the DSS Shares are being acquired
for Sellerβs own account and not with a present view towards
the public sale or distribution thereof, except pursuant to sales
registered or exempted from registration under the Securities
Act.
Β
(b)Β Accredited Investor Status.
Seller is an βaccredited investorβ as that term is
defined in Rule 501(a) of Regulation D under the Securities Act (an
βAccredited Investorβ).
Β
(c)Β Reliance on Exemptions. Seller
understands that the DSS Shares are being issued to Seller in
reliance upon specific exemptions from the registration
requirements of United States federal and state securities Laws and
that DSS and Buyer are relying upon the truth and accuracy of, and
Sellerβs compliance with, the representations, warranties,
agreements, acknowledgments and understandings of Seller set forth
herein in order to determine the availability of such exemptions
and the eligibility of Seller to acquire the DSS
Shares.
Β
(d)Β Information. Seller and its
advisors, if any, have been furnished with all materials relating
to the business, finances and operations of DSS and materials
relating to the issuance of the DSS Shares that have been requested
by Seller or its advisors. Seller and its advisors, if any, have
been afforded the opportunity to ask questions of the management of
DSS. Seller understands that its investment in the DSS Shares
involves a significant degree of risk. Seller is not aware of any
facts that may constitute a breach of any of DSSβs or
Buyerβs representations and warranties made herein. Seller
has received and reviewed the SEC Reports and consents to such SEC
Reports being delivered to Seller via the DSSβs filings with
the SEC through its electronic XXXXX database.
Β
(e)Β Governmental Review. Seller
understands that no United States federal or state agency or any
other Governmental Authority has passed upon or made any
recommendation or endorsement of the DSS Shares.
Β
(f)Β Transfer or Resale. Seller
understands that the sale or re-sale of the DSS Shares has not been
and is not being registered under the Securities Act or any
applicable state or foreign securities Laws, and the DSS Shares may
not be Transferred unless Β the DSS Shares are sold pursuant to
an effective registration statement under the Securities Act,
Β Seller shall have delivered to DSS, at the cost of Seller, an
opinion of U. S. securities counsel reasonably satisfactory to DSS
that shall be in form, substance and scope customary for opinions
of counsel in comparable transactions to the effect that the DSS
Shares to be sold or transferred may be sold or transferred
pursuant to an exemption from the registration requirements of the
Securities Act (including Rule 144 promulgated under the Securities
Act (or a successor rule) (βRule 144β)), which opinion is
accepted by DSS, Β the DSS Shares are sold or transferred to an
Affiliate of Seller who agrees to sell or otherwise transfer the
DSS Shares only in accordance with this Section 3.29 and who is an
Accredited Investor, or Β the DSS Shares are sold pursuant to
Regulation S under the Securities Act (or a successor rule)
(βRegulation
Sβ), and Seller shall have delivered to DSS, at the
cost of Seller, an opinion of U. S. securities counsel reasonably
satisfactory to DSS that shall be in form, substance and scope
customary for opinions of counsel in corporate transactions, which
opinion shall be accepted by DSS; (ii) any sale of DSS Shares made
in reliance on Rule 144 may be made only in accordance with the
terms of said Rule and further, if said Rule is not applicable, any
re-sale of such DSS Shares under circumstances in which the seller
(or the Person through whom the sale is made) may be deemed to be
an underwriter (as that term is defined in the Securities Act) may
require compliance with some other exemption under the Securities
Act or the rules and regulations of the SEC thereunder; and (iii)
neither DSS or Buyer nor any other Person is under any obligation
to register the DSS Shares under the Securities Act or any state or
foreign securities Laws or to comply with the terms and conditions
of any exemption thereunder (in each case).
Β
Β
30
Β
(g)Β Legends. Seller understands
that the DSS Shares, until such time as they may have been
registered under the Securities Act, or may be sold pursuant to
Rule 144 or Regulation S without any restriction as to the number
of securities as of a particular date that can then be immediately
sold or other restrictions, the DSS Shares, and any securities into
which the DSS Shares may be converted or for which they may be
exchanged, will bear a restrictive legend in substantially the
following form (and a stop-transfer order may be placed with
DSSβs transfer agent against transfer of the certificates for
such securities):
Β
βTHE
SECURITIES REPRESENTED BY THIS CERTIFICATE[, AND THE SECURITIES
INTO WHICH THEY ARE CONVERTIBLE,] HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE βSECURITIES
ACTβ), OR ANY STATE OR FOREIGN SECURITIES LAWS, AND NEITHER
SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD,
PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO
AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND
APPLICABLE STATE SECURITIES LAWS OR (2) PURSUANT TO AN AVAILABLE
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND APPLICABLE STATE SECURITIES LAWS, IN WHICH CASE THE HOLDER
MUST, PRIOR TO SUCH TRANSFER, FURNISH TO THE COMPANY AN OPINION OF
COUNSEL, WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO
THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED,
ASSIGNED OR OTHERWISE TRANSFERRED IN THE MANNER CONTEMPLATED
PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE SECURITIES
LAWS.β
Β
The
legend set forth above shall be removed and DSS shall issue a
certificate without such legend to the holder of any DSS Shares
upon which it is stamped, if, unless otherwise required by
applicable state securities Laws, (a) the DSS Shares are registered
for sale under an effective registration statement filed under the
Securities Act or otherwise may be sold pursuant to Rule 144 or
Regulation S without any restriction as to the number of securities
as of a particular date that can then be immediately sold or other
restrictions, or (b) such holder provides DSS with an opinion of
counsel as provided above. Seller agrees to sell all DSS Shares,
including those represented by a certificate(s) from which the
legend has been removed, in compliance with applicable prospectus
delivery requirements, if any. If Seller effects a sale, assignment
or transfer of the DSS Shares in accordance with Section 3.29(f),
DSS shall permit the transfer and shall promptly instruct its
transfer agent to issue one or more certificates or credit shares
to the applicable balance accounts at DTC in such name and in such
denominations as specified by Seller to effect such sale, transfer
or assignment.
Β
Section 3.30Β Proxy Information. The information
contained in the SED Meeting Circular (other than information
supplied by DSS or Buyer or any of their Affiliates specifically
for use therein) as of the date thereof, and up to and including
the date of the SED Stockholdersβ Meeting, (i) will not
contain any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements made
therein, in the light of the circumstances in which they were made,
not misleading, (ii) will disclose all facts that the SED board of
directors deems material to a vote on this Agreement and the
transactions contemplated hereby, and (iii) will comply in all
material respects with the provisions of applicable Singapore law.
The information contained in the DSS Proxy Statement supplied by
SED, Seller or any member of the Company Group, or any of their
Affiliates specifically for use therein as of the date thereof, and
up to and including the date of the DSS Stockholdersβ
Meeting, will not contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances in which
they were made, not misleading.
Β
Β
31
Β
Section 3.31Β Full Disclosure. No representation or
warranty by Seller in this Agreement and no statement contained in
the Disclosure Schedules to this Agreement or any certificate or
other document furnished or to be furnished to Buyer pursuant to
this Agreement contains any untrue statement of a material fact, or
omits to state a material fact necessary to make the statements
contained therein, in light of the circumstances in which they are
made, not misleading.
Β
REPRESENTATIONS
AND WARRANTIES OF BUYER AND DSS
Β
Except
as set forth in the correspondingly numbered Section of the
Disclosure Schedules (which will be delivered to Seller and SED on
or before the SED Circular Filing Date and shall be attached to and
become a part of this Agreement as of the SED Circular Filing
Date), each of DSS and Buyer, jointly and severally, represents and
warrants to each of Seller and SED that the statements contained in
this ARTICLE IV will be true and correct as of the SED Circular
Filing Date.
Β
Section 4.01Β Organization and Authority. Each of
Buyer and DSS is a corporation duly organized, validly existing and
in good standing under the Laws of the state of its incorporation.
Each of Buyer and DSS has full corporate power and authority to
enter into this Agreement and the Ancillary Documents to which it
is a party, to carry out its obligations hereunder and thereunder
and to consummate the transactions contemplated hereby and thereby.
The execution and delivery by each of Buyer and DSS of this
Agreement and any Ancillary Document to which it is a party, the
performance by each of Buyer and DSS of its obligations hereunder
and thereunder and the consummation by each of Buyer and DSS of the
transactions contemplated hereby and thereby have been duly
authorized by all requisite corporate action on the part of each of
Buyer and DSS, subject to the approval of this agreement and the
transactions contemplated hereby by the holders of DSS common
stock. This Agreement has been duly executed and delivered by each
of Buyer and DSS, and (assuming due authorization, execution and
delivery by Seller) this Agreement constitutes a legal, valid and
binding obligation of Buyer or DSS, as the case may be, enforceable
against it in accordance with its terms. When each Ancillary
Document to which it is or will be a party has been duly executed
and delivered by Buyer or DSS (assuming due authorization,
execution and delivery by each other party thereto), such Ancillary
Document will constitute a legal and binding obligation of Buyer or
DSS, as the case may be, enforceable against it in accordance with
its terms.
Β
Section 4.02Β DSS Stockholder Approval. The approval
by the holders of DSS common stock is the only vote of holders of
any class of DSS capital stock necessary to adopt and approve this
Agreement and the transactions contemplated hereby. The affirmative
vote of Persons holding at least a majority of the issued and
outstanding shares of DSS common stock as of the record date for
the DSS Stockholdersβ Meeting is the only vote of DSS
stockholders required to approve the this Agreement and the
transactions contemplated hereby. DSSβs board of directors,
by resolution duly adopted by the unanimous vote of the entire
board of directors at a meeting duly called and held or acting by
unanimous written consent, has (i) determined that this Agreement
and the transactions contemplated hereby are advisable and are in
the best interests of DSS and its stockholders, (ii) authorized and
approved this Agreement and the transactions contemplated hereby,
(iii) directed that the this Agreement and the transactions
contemplated hereby be submitted for consideration at the DSS
Stockholdersβ Meeting, and (iv) recommended that its
stockholders approve the this Agreement and the transactions
contemplated hereby.
Β
Β
32
Β
Section 4.03Β No
Conflicts; Consents. The execution, delivery and performance
by each of Buyer and DSS of this Agreement and the Ancillary
Documents to which it is a party, and the consummation of the
transactions contemplated hereby and thereby, do not and will not:
(a) conflict with or result in a violation or breach of, or default
under, any provision of its certificate of incorporation, by-laws
or other organizational documents; (b) conflict with or result in a
violation or breach of any provision of any Law or Governmental
Order applicable to it; or (c) require the consent, notice or other
action by any Person under any material Contract to which it is a
party. No consent, approval, Permit, Governmental Order,
declaration or filing with, or notice to, any Governmental
Authority is required by or with respect to Buyer or DSS in
connection with the execution and delivery of this Agreement and
the Ancillary Documents and the consummation of the transactions
contemplated hereby and thereby.
Β
Section 4.04Β Investment Purpose. Buyer is acquiring
the Impact Shares solely for its own account for investment
purposes and not with a view to, or for offer or sale in connection
with, any distribution thereof. Buyer acknowledges that the Impact
Shares are not registered under the Securities Act, or any state or
foreign securities laws, and that the Impact Shares may not be
transferred or sold except pursuant to the registration provisions
of the Securities Act or pursuant to an applicable exemption
therefrom and subject to state securities laws and regulations, as
applicable.
Β
Section 4.05Β Brokers. No broker, finder or
investment banker is entitled to any brokerage, finderβs or
other fee or commission in connection with the transactions
contemplated by this Agreement or any Ancillary Document based upon
arrangements made by or on behalf of Buyer or DSS.
Β
Section 4.06Β Legal Proceedings. There are no Actions
pending or, to Buyerβs knowledge, threatened against or by
Buyer or any Affiliate of Buyer that challenge or seek to prevent,
enjoin or otherwise delay the transactions contemplated by this
Agreement. No event has occurred or circumstances exist that may
give rise or serve as a basis for any such Action.
Β
Section 4.07Β DSS Shares. Assuming the accuracy of
the representations and warranties made by SED and the Seller
herein, the DSS Common Shares and the DSS Preferred Shares, when
issued and delivered as provided herein, and the shares of DSS
common stock issuable upon conversion of the DSS Preferred Shares,
upon conversion thereof as provided in the Certificate of
Designations, will have been duly authorized, and will be validly
issued, fully paid and non-assessable, and will have been issued in
accordance with a valid exemption to the registration requirements
of the Securities Act.
Β
Section 4.08Β SEC
Reports.
Β
(a)Β DSS has filed all
reports, schedules, forms, statements and other documents required
to be filed by it with the SEC since January 1, 2018, pursuant to
the Exchange Act (the βSEC
Reportsβ).
Β
(b)Β As of their
respective dates, the SEC Reports complied in all material respects
with the requirements of the Exchange Act and the rules and
regulations of the SEC promulgated thereunder, and none of the SEC
Reports, when filed, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not
misleading. The consolidated financial statements of DSS included
in the SEC Reports comply in all respects with applicable
accounting requirements and the rules and regulations of the SEC
with respect thereto as in effect at the time of filing, were
prepared in accordance with GAAP applied on a consistent basis
during the periods involved (except as may be indicated in the
notes thereto, or, in the case of unaudited statements as permitted
by Form 10-Q), and fairly present in all material respects (subject
in the case of unaudited statements, to normal, recurring audit
adjustments) the financial position of DSS and its subsidiaries as
at the dates thereof and the results of their operations and cash
flows for the periods then ended.
Β
Β
33
Β
(c)Β Internal
Accounting Controls. As set forth in the SEC Reports, DSS and its
subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (a) transactions
are executed in accordance with managementβs general or
specific authorizations, (b) transactions are recorded as necessary
to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (c) access to assets is
permitted only in accordance with managementβs general or
specific authorization, and (d) the recorded accountability for
assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any
differences.
Β
Section 4.09Β Proxy Information. The information
contained in the DSS Proxy Statement (other than information
supplied by SED, Seller or any member of the Company Group, or any
of their Affiliates specifically for use therein) as of the date
thereof, and up to and including the date of the DSS
Stockholdersβ Meeting, (i) will not contain any untrue
statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the
light of the circumstances in which they were made, not misleading,
(ii) will disclose all facts that the DSS board of directors deems
material to a vote on this Agreement and the transactions
contemplated hereby, and (iii) will comply in all material respects
with the provisions of the Exchange Act. The information contained
in the sed Meeting Circular supplied by DSS, Buyer or any of their
Affiliates specifically for use therein as of the date thereof, and
up to and including the date of the SED Stockholdersβ
Meeting, will not contain any untrue statement of a material fact
or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances in which
they were made, not misleading.
Β
ARTICLE V
COVENANTS
Β
Β
Section 5.01Β Conduct of Business Prior to the
Closing. From the date hereof until the Closing, except as
otherwise provided in this Agreement or consented to in writing by
Buyer (which consent shall not be unreasonably withheld or
delayed), each of Seller and SED shall, and shall cause each member
of the Company Group to, (x) conduct its business in the ordinary
course of business consistent with past practice; and (y) use
reasonable best efforts to maintain and preserve intact the current
organization, business and franchise of each member of the Company
Group and to preserve the rights, franchises, goodwill and
relationships of its employees, customers, lenders, suppliers,
regulators and others having business relationships with any member
of the Company Group. Without limiting the foregoing, from the date
hereof until the Closing Date, each of Seller and SED
shall:
Β
(a)Β cause each member
of the Company Group to preserve and maintain all of its
Permits;
Β
(b)Β cause each member
of the Company Group to pay its debts, Taxes and other obligations
when due;
Β
(c)Β cause each member
of the Company Group to maintain the properties and assets owned,
operated or used by it in the same condition as they were on the
date of this Agreement, subject to reasonable wear and
tear;
Β
Β
34
Β
(d)Β cause each member
of the Company Group to continue in full force and effect without
modification all Insurance Policies, except as required by
applicable Law;
Β
(e)Β cause each member
of the Company Group to defend and protect its properties and
assets from infringement or usurpation;
Β
(f)Β cause each member
of the Company Group to perform all of its obligations under all
Contracts relating to or affecting its properties, assets or
business;
Β
(g)Β cause each member
of the Company Group to maintain its books and records in
accordance with past practice;
Β
(h)Β cause each member
of the Company Group to comply in all material respects with all
applicable Laws; and
Β
(i)Β cause each member
of the Company Group not to take or permit any action that would
cause any of the changes, events or conditions described in Section
3.09 to occur.
Β
Section 5.02Β Access to Information. From the date
hereof until the Closing, each of Seller and SED shall, and shall
cause each member of the Company Group to, (a) afford Buyer and its
Representatives full and free access to and the right to inspect
all of the Real Property, properties, assets, premises, books and
records, Contracts and other documents and data related to each
member of the Company Group; (b) furnish Buyer and its
Representatives with such financial, operating and other data and
information related to each member of the Company Group as Buyer or
any of its Representatives may reasonably request; and (c) instruct
the Representatives of Seller, SED and each member of the Company
Group to cooperate with Buyer in its investigation of the Company
Group. Any investigation pursuant to this Section 5.02 shall be
conducted in such manner as not to interfere unreasonably with the
conduct of the business of Seller, SED or any member of the Company
Group. No investigation by Buyer or other information received by
Buyer shall operate as a waiver or otherwise affect any
representation, warranty or agreement given or made by Seller or
SED in this Agreement.
Β
Β
(a)Β Each of Seller and SED shall not, and
shall not authorize or permit any of its Affiliates (including any
member of the Company Group) or any of its or their Representatives
to, directly or indirectly, (i) encourage, solicit, initiate,
facilitate or continue inquiries regarding an Acquisition Proposal;
(ii) enter into discussions or negotiations with, or provide any
information to, any Person concerning a possible Acquisition
Proposal; or (iii) enter into any agreements or other instruments
(whether or not binding) regarding an Acquisition Proposal. Each of
Seller and SED shall immediately cease and cause to be terminated,
and shall cause its Affiliates (including each member of the
Company Group) and all of its and their Representatives to
immediately cease and cause to be terminated, all existing
discussions or negotiations with any Persons conducted heretofore
with respect to, or that could lead to, an Acquisition Proposal.
For purposes hereof, βAcquisition Proposalβ shall mean
any inquiry, proposal or offer from any Person (other than Buyer or
any of its Affiliates) concerning (i) a merger, consolidation,
liquidation, recapitalization, share exchange or other business
combination transaction involving any member of the Company Group;
(ii) the issuance or acquisition of shares of capital stock or
other equity securities of any member of the Company Group; or
(iii) the sale, lease, exchange or other disposition of any
significant portion of any member of the Company Groupβs
properties or assets.
Β
Β
35
Β
(b)Β In addition to the
other obligations under this Section 5.03, each of Seller and SED
shall promptly (and in any event within one Business Day after
receipt thereof by Seller, SED or its Representatives) advise Buyer
orally and in writing of any Acquisition Proposal, any request for
information with respect to any Acquisition Proposal, or any
inquiry with respect to or which could reasonably be expected to
result in an Acquisition Proposal, the material terms and
conditions of such request, Acquisition Proposal or inquiry, and
the identity of the Person making the same.
Β
(c)Β Each of Seller and
SED agrees that the rights and remedies for noncompliance with this
Section 5.03 shall include having such provision specifically
enforced by any court having equity jurisdiction, it being
acknowledged and agreed that any such breach or threatened breach
shall cause irreparable injury to Buyer and that money damages
would not provide an adequate remedy to Buyer.
Β
Β
(a)Β From the date
hereof until the Closing, each of Seller and SED shall promptly
notify Buyer in writing of:
Β
(i)Β any fact,
circumstance, event or action the existence, occurrence or taking
of which (A) has had, or could reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse
Effect, (B) has resulted in, or could reasonably be expected to
result in, any representation or warranty made by Seller or SED
hereunder not being true and correct or (C) has resulted in, or
could reasonably be expected to result in, the failure of any of
the conditions set forth in Section 7.02 to be
satisfied;
Β
(ii)Β any notice or
other communication from any Person alleging that the consent of
such Person is or may be required in connection with the
transactions contemplated by this Agreement;
Β
(iii)Β any notice or
other communication from any Governmental Authority in connection
with the transactions contemplated by this Agreement;
and
Β
(iv)Β any Actions
commenced or, to Sellerβs Knowledge, threatened against,
relating to or involving or otherwise affecting Seller, SED or any
member of the Company Group that, if pending on the date of this
Agreement, would have been required to have been disclosed pursuant
to Section 3.18 or that relates to the consummation of the
transactions contemplated by this Agreement.
Β
(b)Β Buyerβs
receipt of information pursuant to this Section 5.04 shall not
operate as a waiver or otherwise affect any representation,
warranty or agreement given or made by Seller or SED in this
Agreement (including Section 8.02 and Section 9.01(b)) and shall
not be deemed to amend or supplement the Disclosure
Schedules.
Β
Section 5.05Β Confidentiality. From and after the
Closing, each of Seller and SED shall, and shall cause its
Affiliates to, hold, and shall use its reasonable best efforts to
cause its or their respective Representatives to hold, in
confidence any and all information, whether written or oral,
concerning any member of the Company Group, except to the extent
that Seller or SED can show that such information (a) is generally
available to and known by the public through no fault of Seller,
SED any of their Affiliates or their respective Representatives; or
(b) is lawfully acquired by Seller, SED any of their Affiliates or
their respective Representatives from and after the Closing from
sources which are not prohibited from disclosing such information
by a legal, contractual or fiduciary obligation. If Seller, SED or
any of their Affiliates or their respective Representatives are
compelled to disclose any information by judicial or administrative
process or by other requirements of Law, Seller or SED shall
promptly notify Buyer in writing and shall disclose only that
portion of such information which Seller is advised by its counsel
in writing is legally required to be disclosed, provided that Seller or SED, as the
case may be, shall use reasonable best efforts to obtain an
appropriate protective order or other reasonable assurance that
confidential treatment will be accorded such
information.
Β
Β
36
Β
Β
Β
(a)Β For a period of five (5) years
commencing on the Closing Date (the βRestricted Periodβ), neither of
Seller nor SED shall, nor shall permit any of its Affiliates to,
directly or indirectly, (i) engage in or assist others in engaging
in the Restricted Business in the Territory; (ii) have an interest
in any Person that engages directly or indirectly in the Restricted
Business in the Territory in any capacity, including as a partner,
shareholder, member, employee, principal, agent, trustee or
consultant; or (iii) intentionally interfere in any material
respect with the business relationships (whether formed prior to or
after the date of this Agreement) between any member of the Company
Group and customers or suppliers of any member of the Company
Group. Notwithstanding the foregoing clause (ii), Seller, SED or
their Affiliates may own, directly or indirectly, solely as an
investment, securities of any such Person that are traded on any
national securities exchange if none of Seller, SED or any of their
Affiliates is not a controlling Person of, or a member of a group
which controls, such Person and do not, in the aggregate, directly
or indirectly, own 5% or more of any class of securities of such
Person.
Β
(b)Β During the Restricted Period, neither
of Seller nor SED shall, nor shall permit any of its Affiliates to,
directly or indirectly, hire or solicit any employee of the Company
Group or encourage any such employee to leave such employment or
hire any such employee who has left such employment, except
pursuant to a general solicitation which is not directed
specifically to any such employees; provided, that nothing in this Section
5.06(b) shall prevent Seller, SED or any of their Affiliates from
hiring any employee whose employment has been terminated by the
Company Group or Buyer.
Β
(c)Β During the
Restricted Period, neither of Seller nor SED shall, nor shall
permit any of its Affiliates to, directly or indirectly, solicit or
entice, or attempt to solicit or entice, any clients or customers
of any member of the Company Group or potential clients or
customers of any member of the Company Group for purposes of
diverting their business or services from any member of the Company
Group.
Β
(d)Β Each of Seller and
SED acknowledges that a breach or threatened breach of this Section
5.06 would give rise to irreparable harm to Buyer and DSS, for
which monetary damages would not be an adequate remedy, and hereby
agrees that in the event of a breach or a threatened breach by
Seller or SED of any such obligations, Buyer or DSS shall, in
addition to any and all other rights and remedies that may be
available to it in respect of such breach, be entitled to equitable
relief, including a temporary restraining order, an injunction,
specific performance and any other relief that may be available
from a court of competent jurisdiction (without any requirement to
post bond).
Β
(e)Β Each of Seller and SED acknowledges
that the restrictions contained in this Section 5.06 are reasonable
and necessary to protect the legitimate interests of Buyer and DSS
and constitute a material inducement to each of Buyer and DSS to
enter into this Agreement and consummate the transactions
contemplated by this Agreement. In the event that any covenant
contained in this Section 5.06 should ever be adjudicated to exceed
the time, geographic, product or service, or other limitations
permitted by applicable Law in any jurisdiction, then any court is
expressly empowered to reform such covenant, and such covenant
shall be deemed reformed, in such jurisdiction to the maximum time,
geographic, product or service, or other limitations permitted by
applicable Law. The covenants contained in this Section 5.06 and
each provision hereof are severable and distinct covenants and
provisions. The invalidity or unenforceability of any such covenant
or provision as written shall not invalidate or render
unenforceable the remaining covenants or provisions hereof, and any
such invalidity or unenforceability in any jurisdiction shall not
invalidate or render unenforceable such covenant or provision in
any other jurisdiction.
Β
Β
37
Β
Β
Β
(a)Β Each party hereto
shall, as promptly as possible, (i) make, or cause or be made, all
filings and submissions required under any Law applicable to such
party or any of its Affiliates; and (ii) use reasonable best
efforts to obtain, or cause to be obtained, all consents,
authorizations, orders and approvals from all Governmental
Authorities that may be or become necessary for its execution and
delivery of this Agreement and the performance of its obligations
pursuant to this Agreement and the Ancillary Documents. Each party
shall cooperate fully with the other Party and its Affiliates in
promptly seeking to obtain all such consents, authorizations,
orders and approvals. The parties hereto shall not willfully take
any action that will have the effect of delaying, impairing or
impeding the receipt of any required consents, authorizations,
orders and approvals.
Β
(b)Β The Parties shall
use reasonable best efforts to give all notices to, and obtain all
consents from, all third parties that are described in Section 3.05
and Section 4.03 of the Disclosure Schedules.
Β
(c)Β Without limiting
the generality of the Partiesβ undertakings pursuant to
subsections (a) and (b) above, each of the Parties hereto shall use
all reasonable best efforts to:
Β
(i)Β respond to any
inquiries by any Governmental Authority regarding antitrust or
other matters with respect to the transactions contemplated by this
Agreement or any Ancillary Document;
Β
(ii)Β avoid the
imposition of any order or the taking of any action that would
restrain, alter or enjoin the transactions contemplated by this
Agreement or any Ancillary Document; and
Β
(iii)Β in the event any
Governmental Order adversely affecting the ability of the Parties
to consummate the transactions contemplated by this Agreement or
any Ancillary Document has been issued, to have such Governmental
Order vacated or lifted.
Β
(d)Β If any consent,
approval or authorization necessary to preserve any right or
benefit under any Contract to which any member of the Company Group
is a party is not obtained prior to the Closing, Seller and SED
shall, subsequent to the Closing, cooperate with Buyer and the
Company Group in attempting to obtain such consent, approval or
authorization as promptly thereafter as practicable. If such
consent, approval or authorization cannot be obtained, Seller and
SED shall use their reasonable best efforts to provide the
applicable member of the Company Group with the rights and benefits
of the affected Contract for the term thereof, and, if Seller and
SED provide such rights and benefits, the applicable member of the
Company Group shall assume all obligations and burdens
thereunder.
Β
(e)Β All analyses,
appearances, meetings, discussions, presentations, memoranda,
briefs, filings, arguments, and proposals made by or on behalf of
either party before any Governmental Authority or the staff or
regulators of any Governmental Authority, in connection with the
transactions contemplated hereunder (but, for the avoidance of
doubt, not including any interactions between Seller, SED or any
member of the Company Group with Governmental Authorities in the
ordinary course of business, any disclosure which is not permitted
by Law or any disclosure containing confidential information) shall
be disclosed to the other parties hereunder in advance of any
filing, submission or attendance, it being the intent that the
Parties will consult and cooperate with one another, and consider
in good faith the views of one another, in connection with any such
analyses, appearances, meetings, discussions, presentations,
memoranda, briefs, filings, arguments, and proposals. Each party
shall give notice to the other Party with respect to any meeting,
discussion, appearance or contact with any Governmental Authority
or the staff or regulators of any Governmental Authority, with such
notice being sufficient to provide the other Party with the
opportunity to attend and participate in such meeting, discussion,
appearance or contact.
Β
Β
38
Β
Β
(f)Β Notwithstanding the
foregoing, nothing in this Section 5.07 shall require, or be
construed to require, Buyer or any of its Affiliates to agree to
(i) sell, hold, divest, discontinue or limit, before or after the
Closing Date, any assets, businesses or interests of Buyer, any
member of the Company Group or any of their respective Affiliates;
(ii) any conditions relating to, or changes or restrictions in, the
operations of any such assets, businesses or interests which, in
either case, could reasonably be expected to result in a Company
Material Adverse Effect or materially and adversely impact the
economic or business benefits to Buyer of the transactions
contemplated by this Agreement; or (iii) any material modification
or waiver of the terms and conditions of this
Agreement.
Β
Β
(a)Β In order to
facilitate the resolution of any claims made against or incurred by
Seller or SED prior to the Closing, or for any other reasonable
purpose, for a period of ten (10) years after the Closing, Buyer
shall:
Β
(i)Β retain the books
and records (including personnel files) of each member of the
Company Group relating to periods prior to the Closing in a manner
reasonably consistent with the prior practices of the applicable
member of the Company Group; and
Β
(ii)Β upon reasonable
notice, afford the Representatives of Seller and SED reasonable
access (including the right to make, at their expense,
photocopies), during normal business hours, to such books and
records;
Β
Β provided,
however, that any books and records related to Tax matters
shall be retained pursuant to the periods set forth in ARTICLE
VI.
Β
(b)Β In order to
facilitate the resolution of any claims made by or against or
incurred by Buyer or any member of the Company Group after the
Closing, or for any other reasonable purpose, for a period of ten
(10) years following the Closing, Seller and SED
shall:
Β
(i)Β retain the books
and records (including personnel files) of Seller and SED which
relate to each member of the Company Group and its operations for
periods prior to the Closing; and
Β
(ii)Β upon reasonable
notice, afford the Representatives of Buyer or any member of the
Company Group reasonable access (including the right to make, at
Buyerβs expense, photocopies), during normal business hours,
to such books and records;
Β
provided, however, that any books and
records related to Tax matters shall be retained pursuant to the
periods set forth in ARTICLE VI.
Β
(c)Β No Party shall be
obligated to provide any other Party with access to any books or
records (including personnel files) pursuant to this Section 5.08
where such access would violate any Law.
Β
Section 5.09Β Closing Conditions From the date hereof
until the Closing, each Party hereto shall, and Seller and SED
shall cause each member of the Company Group to, use reasonable
best efforts to take such actions as are necessary to expeditiously
satisfy the closing conditions set forth in ARTICLE VII
hereof.
Β
Β
39
Β
Β
Section 5.10Β DSS Stockholder Approval. As promptly
as practicable after the approval of the transactions contemplated
by this Agreement by all applicable Governmental Authorities, in
accordance with DSSβs certificate of incorporation and
by-laws, applicable Law and this Agreement, DSS shall submit the
this Agreement and the transactions contemplated hereby to its
stockholders for approval at the DSS Stockholdersβ Meeting
with the recommendation that its stockholders approve this
Agreement and the transactions contemplated hereby.
Β
Section 5.11Β DSS
Proxy Statement.
Β
(a)Β Seller and SED
shall use their best efforts to deliver to Buyer and DSS a complete
set of Disclosure Schedules in accordance with the introduction to
ARTICLE III within fourteen (14) days after the date of this
Agreement. The Parties shall
cooperate with one another in the preparation of the DSS Proxy
Statement. DSS will provide SED
and Seller and their counsel with a reasonable opportunity to
review and comment on the DSS Proxy Statement (and all supplements
and amendments thereto) prior to delivering it to holders of DSS
Common Stock, and will provide SED and Seller and their counsel
with a copy of the final DSS Proxy Statement (and all supplements
and amendments thereto) promptly after it is delivered to holders
of the DSS common stock. Each Party shall promptly notify the
others if at any time it becomes aware that the DSS Proxy Statement
contains any untrue statement of a material fact or omits to state
a material fact required to be stated therein or necessary to make
the statements contained therein, in light of the circumstances
under which they were made, not misleading. In such event, DSS
shall prepare and deliver to holders of DSS common stock a
supplement or an amendment to the DSS Proxy Statement that corrects
such misstatement or omission.
Β
(b)Β On the DSS Proxy
Filing Date, each of Seller and SED shall deliver to DSS and Buyer
a certificate, dated the DSS Proxy Filing Date and signed by a duly
authorized officer, that (i) other than the representations and
warranties of Seller and SED contained in Section 3.01, Section
3.02, Section 3.03, Section 3.07(a) and Section 3.28, the
representations and warranties of Seller and SED contained in this
Agreement, the Ancillary Documents and any certificate or other
writing delivered pursuant hereto are true and correct in all
respects (in the case of any representation or warranty qualified
by materiality or Company Material Adverse Effect) or in all
material respects (in the case of any representation or warranty
not qualified by materiality or Company Material Adverse Effect) on
and as of the DSS Proxy Filing Date a with the same effect as
though made at and as of such date (except those representations
and warranties that address matters only as of a specified date,
the accuracy of which shall be determined as of that specified date
in all respects), and (ii) the representations and warranties of
Seller and SED contained in Section 3.01, Section 3.02, Section
3.03, Section 3.07(a) and Section 3.28 shall be true and correct in
all respects on and as of the DSS Proxy Filing Date with the same
effect as though made at and as of such date (except those
representations and warranties that address matters only as of a
specified date, the accuracy of which shall be determined as of
that specified date in all respects)
Β
Section 5.12Β SED Stockholder Approval. As promptly
as practicable after the approval of the Contemplated Transactions
by all applicable Governmental Authorities, in accordance with
SEDβs constitution, applicable Law and this Agreement, SED
shall submit the this Agreement and the transactions contemplated
hereby to its stockholders for approval at the SED
Stockholdersβ Meeting with the recommendation that its
stockholders approve this Agreement and the transactions
contemplated hereby.
Β
Β
40
Β
Β
Section 5.13Β SED
Meeting Circular.
Β
(a)Β Buyer and DSS shall
use their best efforts to deliver to Seller and SED a complete set
of Disclosure Schedules in accordance with the introduction to
ARTICLE IV within fourteen (14) days after the date of this
Agreement. The Parties shall cooperate with one another in the
preparation of the SED Meeting Circular. SED will provide DSS and
Buyer and their counsel with a reasonable opportunity to review and
comment on the SED Meeting Circular (and all supplements and
amendments thereto) prior to delivering it to holders of SED common
stock, and will provide SED and Buyer and their counsel with a copy
of the final SED Meeting Circular (and all supplements and
amendments thereto) promptly after it is delivered to holders of
the SED common stock. Each Party shall promptly notify the others
if at any time it becomes aware that the SED Meeting Circular
contains any untrue statement of a material fact or omits to state
a material fact required to be stated therein or necessary to make
the statements contained therein, in light of the circumstances
under which they were made, not misleading. In such event, SED
shall prepare and deliver to holders of SED common stock a
supplement or an amendment to the SED Meeting Circular that
corrects such misstatement or omission.
Β
(b)Β On the SED
Circular Filing Date, each of Buyer and DSS shall deliver to SED
and Seller a certificate, dated the SED Circular Filing Date and
signed by a duly authorized officer, that (i) other than the
representations and warranties of Buyer and DSS contained in
Section 4.01 and Section 4.04, the representations and warranties
of Buyer contained in this Agreement, the Ancillary Documents and
any certificate or other writing delivered pursuant hereto shall be
true and correct in all respects (in the case of any representation
or warranty qualified by materiality or Company Material Adverse
Effect) or in all material respects (in the case of any
representation or warranty not qualified by materiality or Company
Material Adverse Effect) on and as of the SED Circular Filing Date
with the same effect as though made at and as of such date (except
those representations and warranties that address matters only as
of a specified date, the accuracy of which shall be determined as
of that specified date in all respects), and (ii) the
representations and warranties of Buyer and DSS contained in
Section 4.01 and Section 4.04 shall be true and correct in all
respects on and as of SED Circular Filing Date with the same effect
as though made at and as of such date.
Β
Section 5.14Β Public Announcements. Unless otherwise
required by applicable Law or stock exchange requirements (based
upon the reasonable advice of counsel), no Party to this Agreement
shall make any public announcements in respect of this Agreement or
the transactions contemplated hereby or otherwise communicate with
any news media without the prior written consent of the other Party
(which consent shall not be unreasonably withheld or delayed), and
the Parties shall cooperate as to the timing and contents of any
such announcement.
Β
Section 5.15Β Further Assurances. Following the
Closing, each of the Parties hereto shall, and shall cause their
respective Affiliates to, execute and deliver such additional
documents, instruments, conveyances and assurances and take such
further actions as may be reasonably required to carry out the
provisions hereof and give effect to the transactions contemplated
by this Agreement.
Β
Β
41
Β
Β
TAX
MATTERS
Β
Section 6.01Β Tax Covenants.Β
Β
(a)Β Without the prior
written consent of Buyer, Seller and SED (and, prior to the
Closing, each member of the Company Group, its Affiliates and their
respective Representatives) shall not, to the extent it may affect,
or relate to, any member of the Company Group, make, change or
rescind any Tax election, amend any Tax Return or take any position
on any Tax Return, take any action, omit to take any action or
enter into any other transaction that would have the effect of
increasing the Tax liability or reducing any Tax asset of Buyer or
any member of the Company Group in respect of any Post-Closing Tax
Period. Each of Seller and SED agrees that neither Buyer nor DSS is
to have any liability for any Tax resulting from any action of
Seller, SED, any member of the Company Group, their Affiliates or
any of their respective Representatives, and agrees to indemnify
and hold harmless Buyer and DSS (and, after the Closing Date, any
member of the Company Group) against any such Tax or reduction of
any Tax asset.
Β
(b)Β All transfer,
documentary, sales, use, stamp, registration, value added and other
such Taxes and fees (including any penalties and interest) incurred
in connection with this Agreement and the Ancillary Documents
(including any real property transfer Tax and any other similar
Tax) shall be borne and paid by Seller when due. Seller shall, at
its own expense, timely file any Tax Return or other document with
respect to such Taxes or fees (and Buyer shall cooperate with
respect thereto as necessary).
Β
(c)Β Buyer shall prepare, or cause to be
prepared, all Tax Returns required to be filed by any member of the
Company Group after the Closing Date with respect to a Pre-Closing
Tax Period. Any such Tax Return shall be prepared in a manner
consistent with past practice (unless otherwise required by Law)
and without a change of any election or any accounting method and
shall be submitted by Buyer to Seller (together with schedules,
statements and, to the extent requested by Seller, supporting
documentation) at least 45 days prior to the due date (including
extensions) of such Tax Return. If Seller objects to any item on
any such Tax Return, it shall, within ten days after delivery of
such Tax Return, notify Buyer in writing that it so objects,
specifying with particularity any such item and stating the
specific factual or legal basis for any such objection. If a notice
of objection shall be duly delivered, Buyer and Seller shall
negotiate in good faith and use their reasonable best efforts to
resolve such items. If Buyer and Seller are unable to reach such
agreement within ten days after receipt by Buyer of such notice,
Buyer and Seller shall appoint by mutual agreement the office of an
impartial nationally recognized firm of independent certified
public accountants other than Sellerβs Accountants or
Buyerβs Accountants (the βIndependent Accountantβ) who,
acting as experts and not arbitrators, shall resolve the disputed
items, and any determination by the Independent Accountant shall be
final. The Independent Accountant shall resolve any disputed items
within twenty days of having the item referred to it pursuant to
such procedures as it may require. If the Independent Accountant is
unable to resolve any disputed items before the due date for such
Tax Return, the Tax Return shall be filed as prepared by Buyer and
then amended to reflect the Independent Accountantβs
resolution. The costs, fees and expenses of the Independent
Accountant shall be borne equally by Buyer and Seller. The
preparation and filing of any Tax Return of any member of the
Company Group that does not relate to a Pre-Closing Tax Period
shall be exclusively within the control of Buyer.
Β
Β
42
Β
Β
Section 6.02Β Termination of Existing Tax Sharing
Agreements. Any and all existing Tax sharing agreements
(whether written or not) binding upon any member of the Company
Group shall be terminated as of the Closing Date. After such date
none of the members of the Company Group, Seller, SED nor any of
their Affiliates and their respective Representatives shall have
any further rights or liabilities thereunder.
Β
Section 6.03Β Tax
Indemnification. Each of Seller and SED, jointly and
severally, shall indemnify each member of the Company Group, Buyer,
DSS and each Buyer Indemnitee and hold them harmless from and
against (a) any Loss attributable to any breach of or inaccuracy in
any representation or warranty made in Section 3.23; (b) any Loss
attributable to any breach or violation of, or failure to fully
perform, any covenant, agreement, undertaking or obligation in
ARTICLE VI; (c) all Taxes of any member of the Company Group or
relating to its business for all Pre-Closing Tax Periods; (d) all
Taxes of any member of an affiliated, consolidated, combined or
unitary group of which any member of the Company Group (or any
predecessor of any member of the Company Group) is or was a member
on or prior to the Closing Date by reason of a liability under
Treasury Regulation Section 1.1502-6 or any comparable provisions
of foreign, state or local Law; and (e) any and all Taxes of any
person imposed on any member of the Company Group arising under the
principles of transferee or successor liability or by contract,
relating to an event or transaction occurring before the Closing
Date. In each of the above cases, together with any out-of-pocket
fees and expenses (including attorneysβ and
accountantsβ fees) incurred in connection therewith, each of
Seller and SED, jointly and severally, shall reimburse Buyer for
any Taxes of any member of the Company Group that are the
responsibility of Seller pursuant to this Section 6.03 within ten
Business Days after payment of such Taxes by Buyer, DSS or any
member of the Company Group.
Β
Section 6.04Β Straddle Period. In the case of Taxes
that are payable with respect to a taxable period that begins
before and ends after the Closing Date (each such period, a
βStraddle
Periodβ), the portion of any such Taxes that are
treated as Pre-Closing Taxes for purposes of this Agreement shall
be:
Β
(a)Β in the case of
Taxes (i) based upon, or related to, income, receipts, profits,
wages, capital or net worth, (ii) imposed in connection with the
sale, transfer or assignment of property, or (iii) required to be
withheld, deemed equal to the amount which would be payable if the
taxable year ended with the Closing Date; and
Β
(b)Β in the case of
other Taxes, deemed to be the amount of such Taxes for the entire
period multiplied by a fraction the numerator of which is the
number of days in the period ending on the Closing Date and the
denominator of which is the number of days in the entire
period.
Β
Section 6.05Β Section
338(h)(10) Election.
Β
(a)Β Election. At Buyerβs
option, each member of the Company Group and Seller (and if
necessary, SED) shall join with Buyer in making a timely election
under Section 338(h)(10) of the Code (and any corresponding
election under state, local, and foreign Law) with respect to the
purchase and sale of the Impact Shares of the Company hereunder
(collectively, a βSection
338(h)(10) Electionβ). Seller shall pay any Tax
attributable to the making of the Section 338(h)(10) Election and
each of Seller and SED, jointly and severally, shall indemnify
Buyer and each member of the Company Group against any adverse
consequences arising out of any failure to pay any such
Taxes.
Β
Β
43
Β
Β
(b)Β Allocation of Purchase Price.
If a Section 338(h)(10) Election is made, Seller and Buyer agree
that the Purchase Price and the Liabilities of the Company Group
(plus other relevant items) shall be allocated among the assets of
the Company Group for all purposes (including Tax and financial
accounting) as shown on the allocation schedule (the
βAllocation
Scheduleβ). A draft of the Allocation Schedule shall
be prepared by Seller and delivered to Buyer within thirty (30)
days following the Closing Date for its approval. If Buyer notifies
Seller in writing that Buyer objects to one or more items reflected
in the Allocation Schedule, Seller and Buyer shall negotiate in
good faith to resolve such dispute; provided, however, that if Seller and
Buyer are unable to resolve any dispute with respect to the
Allocation Schedule within sixty (60) days following the Closing
Date, such dispute shall be resolved by the Independent Accountant.
The fees and expenses of such accounting firm shall be borne
equally by Seller and Buyer. Buyer, each member of the Company
Group and Seller shall file all Tax Returns (including amended
returns and claims for refund) and information reports in a manner
consistent with the Allocation Schedule. Any adjustments to the
Purchase Price pursuant to Section 2.04 herein shall be allocated
in a manner consistent with the Allocation Schedule.
Β
Section 6.06Β Contests. Buyer agrees to give written
notice to Seller of the receipt of any written notice by any member
of the Company Group, Buyer, DSS or any of their Affiliates which
involves the assertion of any claim, or the commencement of any
Action, in respect of which an indemnity may be sought by Buyer
pursuant to this ARTICLE VI (a βTax Claimβ); provided, that failure to comply with
this provision shall not affect Buyerβs right to
indemnification hereunder. Buyer shall control the contest or
resolution of any Tax Claim; provided, however, that Buyer shall
obtain the prior written consent of Seller (which consent shall not
be unreasonably withheld or delayed) before entering into any
settlement of a claim or ceasing to defend such claim; and,
provided further, that
Seller shall be entitled to participate in the defense of such
claim and to employ counsel of its choice for such purpose, the
fees and expenses of which separate counsel shall be borne solely
by Seller.
Β
Section 6.07Β Cooperation and Exchange of
Information. The Parties shall provide each other with such
cooperation and information as either of them reasonably may
request of the other in filing any Tax Return pursuant to this
ARTICLE VI or in connection with any audit or other proceeding in
respect of Taxes of any member of the Company Group. Such
cooperation and information shall include providing copies of
relevant Tax Returns or portions thereof, together with
accompanying schedules, related work papers and documents relating
to rulings or other determinations by tax authorities. Each Party
shall retain all Tax Returns, schedules and work papers, records
and other documents in its possession relating to Tax matters of
any member of the Company Group for any taxable period beginning
before the Closing Date until the expiration of the statute of
limitations of the taxable periods to which such Tax Returns and
other documents relate, without regard to extensions except to the
extent notified by the other Party in writing of such extensions
for the respective Tax periods. Prior to transferring, destroying
or discarding any Tax Returns, schedules and work papers, records
and other documents in its possession relating to Tax matters of
any member of the Company Group for any taxable period beginning
before the Closing Date, Seller or SED, on the one hand, or Buyer
or SED, on the other (as the case may be) shall provide the other
Parties with reasonable written notice and offer the other Parties
the opportunity to take custody of such materials.
Β
Section 6.08Β Tax Treatment of Indemnification
Payments. Any indemnification payments pursuant to this
ARTICLE VI shall be treated as an adjustment to the Purchase Price
by the Parties for Tax purposes, unless otherwise required by
Law.
Β
Β
44
Β
Β
Section 6.09Β Survival. Notwithstanding anything in
this Agreement to the contrary, the provisions of Section 3.23 and
this ARTICLE VI shall survive for the full period of all applicable
statutes of limitations (giving effect to any waiver, mitigation or
extension thereof) plus 60 days.
Β
Section 6.10Β Overlap. To the extent that any
obligation or responsibility pursuant to ARTICLE VIII may overlap
with an obligation or responsibility pursuant to this ARTICLE VI,
the provisions of this ARTICLE VI shall govern.
Β
ARTICLE VII
CONDITIONS
TO CLOSING
Β
Section 7.01Β Conditions to Obligations of All
Parties. The obligations of each Party to consummate the
transactions contemplated by this Agreement shall be subject to the
fulfillment, at or prior to the Closing, of each of the following
conditions:
Β
(a)Β This Agreement and
the transactions contemplated hereby shall have been approved by
the requisite vote of (i) the Board of Directors of each of DSS and
Buyer, and (ii) the stockholders of DSS at the DSS
Stockholdersβ Meeting.
Β
(b)Β This Agreement and
the transactions contemplated hereby shall have been approved by
the requisite vote of (i) the Board of Directors of each of SED and
Seller, (ii) the stockholder of the Seller, and (iii) the
stockholders of SED at the SED Stockholdersβ
Meeting.
Β
(c)Β No Governmental
Authority shall have enacted, issued, promulgated, enforced or
entered any Governmental Order which is in effect and has the
effect of making the transactions contemplated by this Agreement
illegal, otherwise restraining or prohibiting consummation of such
transactions or causing any of the transactions contemplated
hereunder to be rescinded following completion
thereof.
Β
(d)Β Seller and SED
shall have received all consents, authorizations, orders and
approvals from the Governmental Authorities referred to in Section
3.05, and Buyer and DSS shall have received all consents,
authorizations, orders and approvals from the Governmental
Authorities referred to in Section 4.03, in each case, in form and
substance reasonably satisfactory to Buyer and Seller, and no such
consent, authorization, order and approval shall have been
revoked.
Β
(e)Β The Certificate of
Designations shall have been filed with the Secretary of State of
the State of New York.
Β
Section 7.02Β Conditions to Obligations of Buyer. The
obligations of Buyer to consummate the transactions contemplated by
this Agreement shall be subject to the fulfillment or Buyerβs
waiver, at or prior to the Closing, of each of the following
conditions:
Β
Β
45
Β
(a)Β On or before the DSS Proxy Filing
Date, Sellerβs Accountants (or another independent public
accounting firm registered with the PCAOB acceptable to DSS and
Buyer in their sole discretion) shall have delivered their audit
report containing their unqualified opinion on the Annual Financial
Statements and their review report on the Interim Financial
Statements in accordance with PCAOB Auditing Standard.
Β
(b)Β No member of the
Company Group shall have any Indebtedness as of the
Closing.
Β
(c)Β The boards of
directors of DSS and Buyer shall have received a written report
from Destum Partners, Inc. (or such other independent financial
advisory firm as the boards shall determine) (the
βValuation
Reportβ) setting forth their determination of the fair
market value of the Impact Shares (which determination shall be
conclusive for all purposes under this Agreement and the Ancillary
Documents) (the βImpact
Valueβ), a copy of which shall be provided to Seller
and SED, and such Valuation Report has not been amended or
rescinded as of the Closing.
Β
(d)Β Other than the
representations and warranties of Seller and SED contained in
Section 3.01, Section 3.02, Section 3.03, Section 3.07(a) and
Section 3.28, the representations and warranties of Seller and SED
contained in this Agreement, the Ancillary Documents and any
certificate or other writing delivered pursuant hereto shall be
true and correct in all respects (in the case of any representation
or warranty qualified by materiality or Company Material Adverse
Effect) or in all material respects (in the case of any
representation or warranty not qualified by materiality or Company
Material Adverse Effect) on and as of the DSS Proxy Filing Date and
on and as of the Closing Date with the same effect as though made
at and as of such date (except those representations and warranties
that address matters only as of a specified date, the accuracy of
which shall be determined as of that specified date in all
respects). The representations and warranties of Seller and SED
contained in Section 3.01, Section 3.02, Section 3.03, Section
3.07(a) and Section 3.28 shall be true and correct in all respects
on and as of the DSS Proxy Filing Date and on and as of the Closing
Date with the same effect as though made at and as of such date
(except those representations and warranties that address matters
only as of a specified date, the accuracy of which shall be
determined as of that specified date in all respects).
Β
(e)Β Each of Seller and SED shall have
duly performed and complied in all material respects with all
agreements, covenants and conditions required by this Agreement and
each of the Ancillary Documents to be performed or complied with by
it prior to or on the Closing Date; provided, that, with respect to
agreements, covenants and conditions that are qualified by
materiality, Seller shall have performed such agreements, covenants
and conditions, as so qualified, in all respects.
Β
(f)Β No Action shall
have been commenced against Buyer, DSS, Seller, SED or any member
of the Company Group, which would prevent the Closing. No
injunction or restraining order shall have been issued by any
Governmental Authority, and be in effect, which restrains or
prohibits any transaction contemplated hereby.
Β
(g)Β All approvals,
consents and waivers that are listed on Section 3.05 of the
Disclosure Schedules shall have been received, and executed
counterparts thereof shall have been delivered to Buyer at or prior
to the Closing.
Β
Β
46
Β
Β
(h)Β From the date of
this Agreement, there shall not have occurred any Company Material
Adverse Effect, nor shall any event or events have occurred that,
individually or in the aggregate, with or without the lapse of
time, could reasonably be expected to result in a Company Material
Adverse Effect.
Β
(i)Β The Ancillary
Documents shall have been executed and delivered by the Parties
thereto and true and complete copies thereof shall have been
delivered to Buyer.
Β
(j)Β Each of Seller and
SED shall have delivered to Buyer a good standing certificate (or
its equivalent) for each member of the Company Group from the
secretary of state or similar Governmental Authority of the
jurisdiction under the Laws in which such entity is
organized.
Β
(k)Β Seller shall have
delivered, or caused to be delivered, to Buyer stock certificates
evidencing the Impact Shares, free and clear of Encumbrances, duly
endorsed in blank or accompanied by stock powers or other
instruments of transfer duly executed in blank and with all
required stock transfer tax stamps affixed.
Β
(l)Β Buyer shall have
received a certificate, dated the Closing Date and signed by a duly
authorized officer of each of Seller and SED, that each of the
conditions set forth in Section 7.02(a) and Section 7.02(e) have
been satisfied.
Β
(m)Β Buyer shall have
received a certificate of the Secretary or an Assistant Secretary
(or equivalent officer) of each of Seller and SED certifying that
attached thereto are true and complete copies of all resolutions
adopted by the board of directors and stockholders of Seller and
SED authorizing the execution, delivery and performance of this
Agreement and the Ancillary Documents and the consummation of the
transactions contemplated hereby and thereby, and that all such
resolutions are in full force and effect and are all the
resolutions adopted in connection with the transactions
contemplated hereby and thereby.
Β
(n)Β Buyer shall have
received a certificate of the Secretary or an Assistant Secretary
(or equivalent officer) of each of Seller and SED certifying the
names and signatures of the officers of Seller authorized to sign
this Agreement, the Ancillary Documents and the other documents to
be delivered hereunder and thereunder.
Β
(o)Β Each of Seller and
SED shall have delivered to Buyer such other documents or
instruments as Buyer reasonably requests and are reasonably
necessary to consummate the transactions contemplated by this
Agreement.
Β
Section 7.03Β Conditions to Obligations of Seller.
The obligations of Seller to consummate the transactions
contemplated by this Agreement shall be subject to the fulfillment
or Sellerβs waiver, at or prior to the Closing, of each of
the following conditions:
Β
(a)Β Other than the representations and
warranties of Buyer and DSS contained in Section 4.01 and Section
4.05, the representations and warranties of Buyer and DSS contained
in this Agreement, the Ancillary Documents and any certificate or
other writing delivered pursuant hereto shall be true and correct
in all respects (in the case of any representation or warranty
qualified by materiality or DSS Material Adverse Effect) or in all
material respects (in the case of any representation or warranty
not qualified by materiality or DSS Material Adverse Effect) on and
as of the SED Circular Filing Date and on and as of the Closing
Date with the same effect as though made at and as of such date
(except those representations and warranties that address matters
only as of a specified date, the accuracy of which shall be
determined as of that specified date in all respects). The
representations and warranties of Buyer and DSS contained in
Section 4.01 and Section 4.05 shall be true and correct in all
respects on and as of the SED Circular Filing Date and on and as of
the Closing Date with the same effect as though made at and as of
such date.
Β
Β
47
Β
Β
(b)Β Each of Buyer and DSS shall have
duly performed and complied in all material respects with all
agreements, covenants and conditions required by this Agreement and
the each of the Ancillary Documents to be performed or complied
with by it prior to or on the Closing Date; provided, that, with respect to
agreements, covenants and conditions that are qualified by
materiality, Buyer shall have performed such agreements, covenants
and conditions, as so qualified, in all respects.
Β
(c)Β No injunction or
restraining order shall have been issued by any Governmental
Authority, and be in effect, which restrains or prohibits any
material transaction contemplated hereby.
Β
(d)Β All approvals,
consents and waivers that are listed on Section 4.03 of the
Disclosure Schedules shall have been received, and executed
counterparts thereof shall have been delivered to Seller at or
prior to the Closing.
Β
(e)Β SED shall have
obtained a written opinion from an independent financial adviser
reasonably satisfactory to Buyer and DSS stating whether this
Agreement and the transactions contemplated by this Agreement are
on normal commercial terms and whether this Agreement and the
transactions contemplated by this Agreement is prejudicial to the
interests of SED and its minority shareholders, a copy of which
will be provided to Buyer and DSS, and such opinion has not been
amended or rescinded as of the Closing.
Β
(f)Β From the date of
this Agreement, there shall not have occurred any DSS Material
Adverse Effect, nor shall any event or events have occurred that,
individually or in the aggregate, with or without the lapse of
time, could reasonably be expected to result in a DSS Material
Adverse Effect.
Β
(g)Β The Ancillary
Documents shall have been executed and delivered by the parties
thereto and true and complete copies thereof shall have been
delivered to Seller.
Β
(h)Β Buyer shall have
delivered to Seller:
Β
(i)Β a duly executed
and authenticated certificate or certificates representing the DSS
Common Shares, free and clear of all Encumbrances, registered in
the name of the Seller; and
Β
(ii)Β a duly executed
and authenticated certificate or certificates representing the DSS
Preferred Shares, free and clear of all Encumbrances, registered in
the name of the Seller.
Β
(i)Β Seller shall have
received a certificate, dated the Closing Date and signed by a duly
authorized officer of each of Buyer and DSS, that each of the
conditions set forth in Section 7.03(a) and Section 7.03(b) have
been satisfied.
Β
(j)Β Seller shall have
received a certificate of the Secretary or an Assistant Secretary
(or equivalent officer) of each of Buyer and DSS certifying that
attached thereto are true and complete copies of all resolutions
adopted by the boards of directors and stockholders of Buyer and of
DSS authorizing the execution, delivery and performance of this
Agreement and the Ancillary Documents and the consummation of the
transactions contemplated hereby and thereby, and that all such
resolutions are in full force and effect and are all the
resolutions adopted in connection with the transactions
contemplated hereby and thereby.
Β
Β
48
Β
Β
(k)Β Seller shall have
received a certificate of the Secretary or an Assistant Secretary
(or equivalent officer) of each of Buyer and DSS certifying the
names and signatures of the officers of Buyer authorized to sign
this Agreement, the Ancillary Documents and the other documents to
be delivered hereunder and thereunder.
Β
(l)Β Each of Buyer and
DSS shall have delivered to Seller such other documents or
instruments as Seller reasonably requests and are reasonably
necessary to consummate the transactions contemplated by this
Agreement.
Β
INDEMNIFICATION
Β
Section 8.01Β Survival. Subject to the limitations
and other provisions of this Agreement, the representations and
warranties contained herein (other than any representations or
warranties contained in Section 3.23 which are subject to ARTICLE
VI) shall survive the Closing and shall remain in full force and
effect until the date that is three (3) years from the Closing
Date; provided, that the
representations and warranties in (a) Section 3.01, Section 3.03,
Section 3.28, Section 4.01 and Section 4.05 shall survive
indefinitely, (b) Section 3.20 shall survive for a period of five
(5) years after the Closing, and (c) Section 3.22 shall survive for
the full period of all applicable statutes of limitations (giving
effect to any waiver, mitigation or extension thereof) plus 60
days. All covenants and agreements of the Parties contained herein
(other than any covenants or agreements contained in ARTICLE VI
which are subject to ARTICLE VI) shall survive the Closing
indefinitely or for the period explicitly specified therein.
Notwithstanding the foregoing, any claims asserted in good faith
with reasonable specificity (to the extent known at such time) and
in writing by notice from the non-breaching party to the breaching
party prior to the expiration date of the applicable survival
period shall not thereafter be barred by the expiration of the
relevant representation or warranty and such claims shall survive
until finally resolved.
Β
Section 8.02Β Indemnification by Seller and SED.
Subject to the other terms and conditions of this ARTICLE VIII,
each of Seller and SED, jointly and severally, shall indemnify and
defend each of DSS, Buyer and their Affiliates (including each
member of the Company Group) and their respective Representatives
(collectively, the βBuyer
Indemniteesβ) against, and shall hold each of them
harmless from and against, and shall pay and reimburse each of them
for, any and all Losses incurred or sustained by, or imposed upon,
the Buyer Indemnitees based upon, arising out of, with respect to
or by reason of:
Β
(a)Β any inaccuracy in or breach of any of
the representations or warranties of Seller or SED contained in
this Agreement or in any certificate or instrument delivered by or
on behalf of Seller pursuant to this Agreement (other than in
respect of Section 3.23, it being understood that the sole remedy
for any such inaccuracy in or breach thereof shall be pursuant to
ARTICLE VI), as of the date such representation or warranty was
made or as if such representation or warranty was made on and as of
the Closing Date (except for representations and warranties that
expressly relate to a specified date, the inaccuracy in or breach
of which will be determined with reference to such specified
date);
Β
Β
49
Β
Β
(b)Β any breach or
non-fulfillment of any covenant, agreement or obligation to be
performed by Seller pursuant to this Agreement (other than any
breach or violation of, or failure to fully perform, any covenant,
agreement, undertaking or obligation in ARTICLE VI, it being
understood that the sole remedy for any such breach, violation or
failure shall be pursuant to ARTICLE VI); or
Β
(c)Β any Transaction
Expenses or Indebtedness of any member of the Company Group
outstanding as of the Closing.
Β
Section 8.03Β Indemnification by Buyer and DSS.
Subject to the other terms and conditions of this ARTICLE VIII,
each of Buyer and DSS, jointly and severally, shall indemnify and
defend each of SED, Seller and their Affiliates and their
respective Representatives (collectively, the βSeller Indemniteesβ) against, and
shall hold each of them harmless from and against, and shall pay
and reimburse each of them for, any and all Losses incurred or
sustained by, or imposed upon, the Seller Indemnitees based upon,
arising out of, with respect to or by reason of:
Β
(a)Β any inaccuracy in or breach of any of
the representations or warranties of Buyer contained in this
Agreement or in any certificate or instrument delivered by or on
behalf of Buyer pursuant to this Agreement, as of the date such
representation or warranty was made or as if such representation or
warranty was made on and as of the Closing Date (except for
representations and warranties that expressly relate to a specified
date, the inaccuracy in or breach of which will be determined with
reference to such specified date); or
Β
(b)Β any breach or
non-fulfillment of any covenant, agreement or obligation to be
performed by Buyer pursuant to this Agreement (other than ARTICLE
VI, it being understood that the sole remedy for any such breach
thereof shall be pursuant to ARTICLE VI).
Β
Secction 8.04Β Certain Limitations. The
indemnification provided for in Section 8.02 and Section 8.03 shall
be subject to the following limitations:
Β
(a)Β Seller and SED
shall not be liable to the Buyer Indemnitees for indemnification
under Section 8.02(a) until the aggregate amount of all Losses in
respect of indemnification under Section 8.02(a) exceeds $500,000
(the βBasketβ),
in which event Seller shall be required to pay or be liable for all
such Losses from the first dollar. The aggregate amount of all
Losses for which Seller and SED shall be liable pursuant to Section
8.02(a) shall not exceed 100% of the nominal value of the Purchase
Price set forth in Section 2.02 (as adjusted pursuant to Section
2.04) (the βCapβ).
Β
(b)Β Buyer and DSS shall
not be liable to the Seller Indemnitees for indemnification under
Section 8.03(a) until the aggregate amount of all Losses in respect
of indemnification under Section 8.03(a) exceeds the Basket, in
which event Buyer shall be required to pay or be liable for all
such Losses from the first dollar. The aggregate amount of all
Losses for which Buyer shall be liable pursuant to Section 8.03(a)
shall not exceed the Cap.
Β
Β
50
Β
Β
(c)Β Notwithstanding the
foregoing, the limitations set forth in Section 8.04(a) and Section
8.04(b) shall not apply to Losses based upon, arising out of, with
respect to or by reason of any inaccuracy in or breach of any
representation or warranty in Section 3.01, Section 3.03, Section
3.20, Section 3.22, Section 3.28, Section 4.01 and Section
4.05.
Β
(d)Β For purposes of
this ARTICLE VIII, any inaccuracy in or breach of any
representation or warranty shall be determined without regard to
any materiality, Company Material Adverse Effect or other similar
qualification contained in or otherwise applicable to such
representation or warranty.
Β
Secction 8.05Β Indemnification Procedures. The party
making a claim under this ARTICLE VIII is referred to as the
βIndemnified
Partyβ, and the party against whom such claims are
asserted under this ARTICLE VIII is referred to as the
βIndemnifying
Partyβ.
Β
(a)Β Third Party Claims. If any
Indemnified Party receives notice of the assertion or commencement
of any Action made or brought by any Person who is not a party to
this Agreement or an Affiliate of a party to this Agreement or a
Representative of the foregoing (a βThird Party Claimβ) against such
Indemnified Party with respect to which the Indemnifying Party is
obligated to provide indemnification under this Agreement, the
Indemnified Party shall give the Indemnifying Party reasonably
prompt written notice thereof, but in any event not later than 10
Business Days after receipt of such notice of such Third Party
Claim. The failure to give such prompt written notice shall not,
however, relieve the Indemnifying Party of its indemnification
obligations, except and only to the extent that the Indemnifying
Party forfeits rights or defenses by reason of such failure. Such
notice by the Indemnified Party shall describe the Third Party
Claim in reasonable detail, shall include copies of all material
written evidence thereof and shall indicate the estimated amount,
if reasonably practicable, of the Loss that has been or may be
sustained by the Indemnified Party. The Indemnifying Party shall
have the right to participate in, or by giving written notice to
the Indemnified Party, to assume the defense of any Third Party
Claim at the Indemnifying Partyβs expense and by the
Indemnifying Partyβs own counsel, and the Indemnified Party
shall cooperate in good faith in such defense; provided, that if the Indemnifying
Party is Seller or SED, such Indemnifying Party shall not have the
right to defend or direct the defense of any such Third Party Claim
that (x) is asserted directly by or on behalf of a Person that is a
supplier or customer of any member of the Company Group, or (y)
seeks an injunction or other equitable relief against the
Indemnified Party. In the event that the Indemnifying Party assumes
the defense of any Third Party Claim, subject to Section 8.05(b),
it shall have the right to take such action as it deems necessary
to avoid, dispute, defend, appeal or make counterclaims pertaining
to any such Third Party Claim in the name and on behalf of the
Indemnified Party. The Indemnified Party shall have the right to
participate in the defense of any Third Party Claim with counsel
selected by it subject to the Indemnifying Partyβs right to
control the defense thereof. The fees and disbursements of such
counsel shall be at the expense of the Indemnified Party,
provided, that if in the
reasonable opinion of counsel to the Indemnified Party, (A) there
are legal defenses available to an Indemnified Party that are
different from or additional to those available to the Indemnifying
Party; or (B) there exists a conflict of interest between the
Indemnifying Party and the Indemnified Party that cannot be waived,
the Indemnifying Party shall be liable for the reasonable fees and
expenses of counsel to the Indemnified Party in each jurisdiction
for which the Indemnified Party determines counsel is required. If
the Indemnifying Party elects not to compromise or defend such
Third Party Claim, fails to promptly notify the Indemnified Party
in writing of its election to defend as provided in this Agreement,
or fails to diligently prosecute the defense of such Third Party
Claim, the Indemnified Party may, subject to Section 8.05(b), pay,
compromise, defend such Third Party Claim and seek indemnification
for any and all Losses based upon, arising from or relating to such
Third Party Claim. Seller and SED, on the one hand, and Buyer and
DSS, on the other hand, shall cooperate with each other in all
reasonable respects in connection with the defense of any Third
Party Claim, including making available (subject to the provisions
of Section 5.05) records relating to such Third Party Claim and
furnishing, without expense (other than reimbursement of actual
out-of-pocket expenses) to the defending party, management
employees of the non-defending party as may be reasonably necessary
for the preparation of the defense of such Third Party
Claim.
Β
Β
51
Β
Β
(b)Β Settlement of Third
Party Claims. Notwithstanding any other provision of this
Agreement, the Indemnifying Party shall not enter into settlement
of any Third Party Claim without the prior written consent of the
Indemnified Party, except as provided in this Section 8.05(b). If a
firm offer is made to settle a Third Party Claim without leading to
liability or the creation of a financial or other obligation on the
part of the Indemnified Party and provides, in customary form, for
the unconditional release of each Indemnified Party from all
liabilities and obligations in connection with such Third Party
Claim and the Indemnifying Party desires to accept and agree to
such offer, the Indemnifying Party shall give written notice to
that effect to the Indemnified Party. If the Indemnified Party
fails to consent to such firm offer within five Business Days after
its receipt of such notice, the Indemnified Party may continue to
contest or defend such Third Party Claim and in such event, the
maximum liability of the Indemnifying Party as to such Third Party
Claim shall not exceed the amount of such settlement offer. If the
Indemnified Party fails to consent to such firm offer and also
fails to assume defense of such Third Party Claim, the Indemnifying
Party may settle the Third Party Claim upon the terms set forth in
such firm offer to settle such Third Party Claim. If the
Indemnified Party has assumed the defense pursuant to Section
8.05(a), it shall not agree to any settlement without the written
consent of the Indemnifying Party (which consent shall not be
unreasonably withheld or delayed).
Β
(c)Β Direct Claims. Any Action by
an Indemnified Party on account of a Loss which does not result
from a Third Party Claim (a βDirect Claimβ) shall be asserted
by the Indemnified Party giving the Indemnifying Party reasonably
prompt written notice thereof, but in any event not later than 10
Business Days after the Indemnified Party becomes aware of such
Direct Claim. The failure to give such prompt written notice shall
not, however, relieve the Indemnifying Party of its indemnification
obligations, except and only to the extent that the Indemnifying
Party forfeits rights or defenses by reason of such failure. Such
notice by the Indemnified Party shall describe the Direct Claim in
reasonable detail, shall include copies of all material written
evidence thereof and shall indicate the estimated amount, if
reasonably practicable, of the Loss that has been or may be
sustained by the Indemnified Party. The Indemnifying Party shall
have 10 Business Days after its receipt of such notice to respond
in writing to such Direct Claim. The Indemnified Party shall allow
the Indemnifying Party and its professional advisors to investigate
the matter or circumstance alleged to give rise to the Direct
Claim, and whether and to what extent any amount is payable in
respect of the Direct Claim and the Indemnified Party shall assist
the Indemnifying Partyβs investigation by giving such
information and assistance (including access to any member of the
Company Groupβs premises and personnel and the right to
examine and copy any accounts, documents or records) as the
Indemnifying Party or any of its professional advisors may
reasonably request. If the Indemnifying Party does not so respond
within such 10 Business Day period, the Indemnifying Party shall be
deemed to have rejected such claim, in which case the Indemnified
Party shall be free to pursue such remedies as may be available to
the Indemnified Party on the terms and subject to the provisions of
this Agreement.
Β
(d)Β Tax Claims. Notwithstanding
any other provision of this Agreement, the control of any claim,
assertion, event or proceeding in respect of Taxes of any member of
the Company Group (including, but not limited to, any such claim in
respect of a breach of the representations and warranties in
Section 3.23 hereof or any breach or violation of or failure to
fully perform any covenant, agreement, undertaking or obligation in
ARTICLE VI) shall be governed exclusively by ARTICLE VI
hereof.
Β
Β
52
Β
Β
Secction 8.06Β Payments. Once a Loss is agreed to by
the Indemnifying Party or finally adjudicated to be payable
pursuant to this ARTICLE VIII, the Indemnifying Party shall satisfy
its obligations within 10 Business Days of such final,
non-appealable adjudication by wire transfer of immediately
available funds. The parties hereto agree that should an
Indemnifying Party not make full payment of any such obligations
within such 10 Business Day period, any amount payable shall accrue
interest from and including the date of agreement of the
Indemnifying Party or final, non-appealable adjudication to but
excluding the date such payment has been made at a rate per annum
equal to eight percent (8%). Such interest shall be calculated
daily on the basis of a 365/366-day year and the actual number of
days elapsed.
Β
Secction 8.07Β Tax Treatment of Indemnification
Payments. All indemnification payments made under this
Agreement shall be treated by the Parties as an adjustment to the
Purchase Price for Tax purposes, unless otherwise required by
Law.
Β
Secction 8.08Β Effect of Investigation. The
representations, warranties and covenants of the Indemnifying
Party, and the Indemnified Partyβs right to indemnification
with respect thereto, shall not be affected or deemed waived by
reason of any investigation made by or on behalf of the Indemnified
Party (including by any of its Representatives) or by reason of the
fact that the Indemnified Party or any of its Representatives knew
or should have known that any such representation or warranty is,
was or might be inaccurate or by reason of the Indemnified
Partyβs waiver of any condition set forth in Section 7.02 or
Section 7.03, as the case may be.
Β
Secction 8.09Β Exclusive Remedies. Subject to Section
5.06 and Section 10.11, the Parties acknowledge and agree that
their sole and exclusive remedy with respect to any and all claims
(other than claims arising from fraud, criminal activity or willful
misconduct on the part of a party hereto in connection with the
transactions contemplated by this Agreement) for any breach of any
representation, warranty, covenant, agreement or obligation set
forth herein or otherwise relating to the subject matter of this
Agreement, shall be pursuant to the indemnification provisions set
forth in ARTICLE VI and this ARTICLE VIII. In furtherance of the
foregoing, each Party hereby waives, to the fullest extent
permitted under Law, any and all rights, claims and causes of
action for any breach of any representation, warranty, covenant,
agreement or obligation set forth herein or otherwise relating to
the subject matter of this Agreement it may have against the other
Parties hereto and their Affiliates and each of their respective
Representatives arising under or based upon any Law, except
pursuant to the indemnification provisions set forth in ARTICLE VI
and this ARTICLE VIII. Nothing in this Section 8.09 shall limit any
Personβs right to seek and obtain any equitable relief to
which any Person shall be entitled or to seek any remedy on account
of any partyβs fraudulent, criminal or intentional
misconduct.
Β
Β
53
Β
Β
ARTICLE IX
TERMINATION
Β
Secction 9.01Β Termination. This Agreement may be
terminated at any time prior to the Closing:
Β
(a)Β by the mutual
written consent of Seller and Buyer;
Β
Β
(i)Β Buyer is not then
in material breach of any provision of this Agreement and there has
been a breach, inaccuracy in or failure to perform any
representation, warranty, covenant or agreement made by Seller
pursuant to this Agreement that would give rise to the failure of
any of the conditions specified in ARTICLE VII and such breach,
inaccuracy or failure has not been cured by Seller within ten days
of Sellerβs receipt of written notice of such breach from
Buyer; or
Β
(ii)Β any of the
conditions set forth in Section 7.01 or Section 7.02 shall not have
been, or if it becomes apparent that any of such conditions will
not be, fulfilled by the date that is one hundred eighty (180) days
after the date of this Agreement, unless such failure shall be due
to the failure of Buyer to perform or comply with any of the
covenants, agreements or conditions hereof to be performed or
complied with by it prior to the Closing;
Β
(c)Β by Seller by
written notice to Buyer if:
Β
(i)Β Seller is not then
in material breach of any provision of this Agreement and there has
been a breach, inaccuracy in or failure to perform any
representation, warranty, covenant or agreement made by Buyer
pursuant to this Agreement that would give rise to the failure of
any of the conditions specified in ARTICLE VII and such breach,
inaccuracy or failure has not been cured by Buyer within ten days
of Buyerβs receipt of written notice of such breach from
Seller; or
Β
(ii)Β any of the
conditions set forth in Section 7.01 or Section 7.03 shall not have
been, or if it becomes apparent that any of such conditions will
not be, fulfilled by the date that is one hundred eighty (180) days
after the date of this Agreement, unless such failure shall be due
to the failure of Seller to perform or comply with any of the
covenants, agreements or conditions hereof to be performed or
complied with by it prior to the Closing;
Β
(d)Β by Buyer or Seller
in the event that (i) there shall be any Law that makes
consummation of the transactions contemplated by this Agreement
illegal or otherwise prohibited or (ii) any Governmental Authority
shall have issued a Governmental Order restraining or enjoining the
transactions contemplated by this Agreement, and such Governmental
Order shall have become final and non-appealable;
Β
Β
54
Β
Β
(e)Β by either Buyer or
Seller if the stockholders of DSS vote on, but fail to approve,
this Agreement and the transactions contemplated hereby at the DSS
Stockholdersβ Meeting (as it may be adjourned and
reconvened); or
Β
(f)Β by either Buyer or
Seller if the stockholders of SED vote on, but fail to approve,
this Agreement and the transactions contemplated hereby at the SED
Stockholdersβ Meeting (as it may be adjourned and
reconvened).
Β
Secction 9.02Β Effect of Termination. In the event of
the termination of this Agreement in accordance with this Article,
this Agreement shall forthwith become void and there shall be no
liability on the part of any Party hereto except:
Β
(a)Β as set forth in
this ARTICLE IX and Section 5.05 and ARTICLE X hereof;
and
Β
(b)Β that nothing
herein shall relieve any Party hereto from liability for any
willful breach of any provision hereof.
Β
ARTICLE X
MISCELLANEOUS
Β
Secction 10.01Β Expenses. Except as otherwise expressly
provided herein, all costs and expenses, including, without
limitation, fees and disbursements of counsel, financial advisors
and accountants, incurred in connection with this Agreement and the
transactions contemplated hereby shall be paid by the Party
incurring such costs and expenses, whether or not the Closing shall
have occurred.
Β
Secction 10.02Β Notices. All notices, requests,
consents, claims, demands, waivers and other communications
hereunder shall be in writing and shall be deemed to have been
given (a) when delivered by hand (with written confirmation of
receipt); (b) when received by the addressee if sent by a
nationally recognized overnight courier (receipt requested); (c) on
the date sent by facsimile or e-mail of a PDF document (with
confirmation of transmission) if sent during normal business hours
of the recipient, and on the next Business Day if sent after normal
business hours of the recipient or (d) on the third day after the
date mailed, by certified or registered mail, return receipt
requested, postage prepaid. Such communications must be sent to the
respective parties at the following addresses (or at such other
address for a party as shall be specified in a notice given in
accordance with this Section 10.02):
Β
If to
Seller:
|
0
Xxxxxxx Xxxxxxxxx
#00-00X,
Xxxxxx Xxxxx Xxx
Xxxxxxxxx
000000
Facsimile:
FAX NUMBER
E-mail:
xxxxx@xxx.xxx.xx
Attention:
Senior Vice President
|
Β
|
Β Β
|
with a
copy to:
|
Xxxxx
Xxx & Bok LLP
Facsimile:
[FAX NUMBER]
E-mail:
[E-MAIL ADDRESS]
Attention:
[ATTORNEY NAME]
|
Β
|
Β
|
If to
DSS or Buyer:
|
000
Xxxxx Xxxx Xxxx, Xxxxx 000
Xxxxxxxxx,
XX 00000
E-mail:
xxxxxxxx@xxxxxxxxx.xxx
Attention:
Chief Executive Officer
Β
|
with a
copy to:
|
Sichenzia
Xxxx Xxxxxxx LLP
0000
Xxxxxx xx xxx Xxxxxxxx,Β
00xx
Β Xxxxx
Xxx
Xxxx, XX 00000
E-mail:
xxxxxxxx@xxx.xxx
Attention:
Xxxxxx Xxxxxx
|
Β
Secction 10.03Β Interpretation. For purposes of this
Agreement, (a) the words βinclude,β
βincludesβ and βincludingβ shall be deemed
to be followed by the words βwithout limitationβ; (b)
the word βorβ is not exclusive; and (c) the words
βherein,β βhereof,β βhereby,β
βheretoβ and βhereunderβ refer to this
Agreement as a whole. Unless the context otherwise requires,
references herein: (x) to Articles, Sections, Disclosure Schedules
and Exhibits mean the Articles and Sections of, and Disclosure
Schedules and Exhibits attached to, this Agreement; (y) to an
agreement, instrument or other document means such agreement,
instrument or other document as amended, supplemented and modified
from time to time to the extent permitted by the provisions thereof
and (z) to a statute means such statute as amended from time to
time and includes any successor legislation thereto and any
regulations promulgated thereunder. This Agreement shall be
construed without regard to any presumption or rule requiring
construction or interpretation against the party drafting an
instrument or causing any instrument to be drafted. The Disclosure
Schedules and Exhibits referred to herein shall be construed with,
and as an integral part of, this Agreement to the same extent as if
they were set forth verbatim herein.
Β
Β
55
Β
Β
Secction 10.04 Headings. The headings in this
Agreement are for reference only and shall not affect the
interpretation of this Agreement.
Β
Secction 10.05 Severability. If any term or provision
of this Agreement is invalid, illegal or unenforceable in any
jurisdiction, such invalidity, illegality or unenforceability shall
not affect any other term or provision of this Agreement or
invalidate or render unenforceable such term or provision in any
other jurisdiction. Except as provided in Section 5.06(e), upon
such determination that any term or other provision is invalid,
illegal or unenforceable, the Parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original
intent of the Parties as closely as possible in a mutually
acceptable manner in order that the transactions contemplated
hereby be consummated as originally contemplated to the greatest
extent possible.
Β
Secction 10.06 Entire Agreement. This Agreement and
the Ancillary Documents constitute the sole and entire agreement of
the Parties to this Agreement with respect to the subject matter
contained herein and therein, and supersede all prior and
contemporaneous understandings and agreements, both written and
oral, with respect to such subject matter. In the event of any
inconsistency between the statements in the body of this Agreement
and those in the Ancillary Documents, the Exhibits and Disclosure
Schedules (other than an exception expressly set forth as such in
the Disclosure Schedules), the statements in the body of this
Agreement will control.
Β
Secction 10.07 Successors and Assigns. This Agreement
shall be binding upon and shall inure to the benefit of the Parties
hereto and their respective successors and permitted assigns.
Neither party may assign its rights or obligations hereunder
without the prior written consent of the other Party, which consent
shall not be unreasonably withheld or delayed; provided, however, that prior to the
Closing Date, Buyer may, without the prior written consent of
Seller, assign all or any portion of its rights under this
Agreement to one or more of its direct or indirect wholly-owned
subsidiaries. No assignment shall relieve the assigning party of
any of its obligations hereunder.
Β
Secction 10.08 No Third-party Beneficiaries. Except as
provided in Section 6.03 and ARTICLE VIII, this Agreement is for
the sole benefit of the Parties hereto and their respective
successors and permitted assigns and nothing herein, express or
implied, is intended to or shall confer upon any other Person or
entity any legal or equitable right, benefit or remedy of any
nature whatsoever under or by reason of this
Agreement.
Β
Secction 10.9 Amendment and Modification; Waiver.
This Agreement may only be amended, modified or supplemented by an
agreement in writing signed by each Party hereto. No waiver by any
Party of any of the provisions hereof shall be effective unless
explicitly set forth in writing and signed by the Party so waiving.
No waiver by any Party shall operate or be construed as a waiver in
respect of any failure, breach or default not expressly identified
by such written waiver, whether of a similar or different
character, and whether occurring before or after that waiver. No
failure to exercise, or delay in exercising, any right, remedy,
power or privilege arising from this Agreement shall operate or be
construed as a waiver thereof; nor shall any single or partial
exercise of any right, remedy, power or privilege hereunder
preclude any other or further exercise thereof or the exercise of
any other right, remedy, power or privilege.
Β
Β
56
Β
Β
Secction 10.10 Governing Law; Submission to Jurisdiction;
Waiver of Jury Trial.Β
Β
(a)Β This Agreement
shall be governed by and construed in accordance with the internal
laws of the State of New York without giving effect to any choice
or conflict of law provision or rule (whether of the State of New
York or any other jurisdiction).
Β
(b)Β ANY LEGAL SUIT,
ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT,
THE Ancillary Documents OR THE TRANSACTIONS CONTEMPLATED HEREBY OR
THEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED
STATES OF AMERICA OR XXX XXXXXX XX XXX XXXXX XX XXX XXXX IN EACH
CASE LOCATED IN THE BOROUGH OF MANHATTAN, CITY OF NEW YORK, AND
EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF
SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING. SERVICE OF
PROCESS, SUMMONS, NOTICE OR OTHER DOCUMENT BY MAIL TO SUCH
PARTYβS ADDRESS SET FORTH HEREIN SHALL BE EFFECTIVE SERVICE
OF PROCESS FOR ANY SUIT, ACTION OR OTHER PROCEEDING BROUGHT IN ANY
SUCH COURT. THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY
OBJECTION TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR ANY
PROCEEDING IN SUCH COURTS AND IRREVOCABLY WAIVE AND AGREE NOT TO
PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH SUIT, ACTION OR
PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN
INCONVENIENT FORUM.
Β
(c)Β EACH PARTY
ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER
THIS AGREEMENT OR THE ANCILLARY DOCUMENTS] IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY
IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR
RELATING TO THIS AGREEMENT, THE Ancillary Documents OR THE
TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY TO THIS
AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF
ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE
EVENT OF A LEGAL ACTION, (B) SUCH PARTY HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER
VOLUNTARILY, AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND
CERTIFICATIONS IN THIS SECTION 10.10(c).
Β
Secction 10.11 Specific Performance. The parties agree
that irreparable damage would occur if any provision of this
Agreement were not performed in accordance with the terms hereof
and that the Parties shall be entitled to specific performance of
the terms hereof, in addition to any other remedy to which they are
entitled at law or in equity.
Β
Secction 10.12 Counterparts. This Agreement may be
executed in counterparts, each of which shall be deemed an
original, but all of which together shall be deemed to be one and
the same agreement. A signed copy of this Agreement delivered by
facsimile, e-mail or other means of electronic transmission shall
be deemed to have the same legal effect as delivery of an original
signed copy of this Agreement.
Β
[Signature page follows.]
Β
Β
57
Β
Β
IN
WITNESS WHEREOF, the Parties hereto have caused this Agreement to
be executed as of the date first written above by their respective
officers thereunto duly authorized.
Β
Β
|
SINGAPORE EDEVELOPMENT LTD.
|
Β
|
By
/s/ Xxxx Xxxx Fai,
XxxxxxxΒ
Name:
XXXX XXXX FAI, XXXXXXX
Title:
EXECUTIVE CHAIRMAN, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE
OFFICER
|
Β
|
Β
|
Β
|
GLOBAL BIOMEDICAL PTE LTD.
|
Β
|
By
/s/ Xxxx Xxxx Fai,
XxxxxxxΒ
Name:
XXXX XXXX FAI, XXXXXXX
Title:
DIRECTOR
|
Β
|
Β
|
Β
|
DOCUMENT SECURITY SYSTEMS, INC.
|
Β
|
By
/s/ Xxxxx X.
XxxxxxxΒ
Name:
XXXXX X. XXXXXXX
Title:
GROUP CHIEF EXECUTIVE OFFICER
|
Β
|
Β
|
Β
|
DSS BIOHEALTH SECURITY INC.
|
Β
|
By
/s/ Xxxxx X.
XxxxxxxΒ
Name:
XXXXX X. XXXXXXX
Title:
DIRECTOR
|
Β
Β
Β
58